| ASOS | 87.1 | 6 | 4 |
| La Roche-Posay | 71.0 | 3 | 4 |
| Sephora | 60.0 | 1 | 7 |
| Lemon8 | 60.0 | 7 | 0 |
| Shopify | 56.1 | 6 | 0 |
| Aveeno | 52.8 | 2 | 2 |
| Credo | 52.8 | 2 | 2 |
| BaiduWiki | 51.7 | 5 | 0 |
| No7 product line | 41.1 | 1 | 2 |
| Rolling Stone | 40.0 | 3 | 0 |
| Bluemercury | 33.3 | 1 | 1 |
| Cetaphil | 33.3 | 1 | 1 |
| Space NK | 33.3 | 1 | 1 |
| Ulta Beauty | 33.3 | 1 | 1 |
| Dermstore | 33.3 | 1 | 1 |
| CeraVe | 33.3 | 1 | 1 |
| Target Corporation | 31.7 | 2 | 0 |
| Neutrogena | 31.7 | 2 | 0 |
| Center for Drug Evaluation and Research | 31.7 | 2 | 0 |
| Miss Selfridge | 31.7 | 2 | 0 |
| Trustpilot | 31.7 | 2 | 0 |
| Beautycounter | 31.7 | 2 | 0 |
| WebMD Magazine | 31.7 | 2 | 0 |
| Color Street | 31.7 | 2 | 0 |
| Structuring integration for patient-centered care: a review-informed ontology-driven modular front-end framework for digital health innovation | 31.7 | 2 | 0 |
| L'Occitane en Provence | 31.0 | 0 | 4 |
| American journal of contact dermatitis : official journal of the American Contact Dermatitis Society | 26.7 | 0 | 3 |
| Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser | 26.7 | 0 | 3 |
| cleanser | 21.1 | 0 | 2 |
| irritant dermatitis | 21.1 | 0 | 2 |
| Kérastase | 21.1 | 0 | 2 |
| Allergic contact dermatitis to synthetic rubber gloves: changing trends in patch test reactions to accelerators | 21.1 | 0 | 2 |
| Chemical assessment of "In-Use" allergic contact dermatitis patch test reagents from dermatology clinics | 21.1 | 0 | 2 |
| A review of perineal skin care protocols and skin barrier product use | 21.1 | 0 | 2 |
| Patch test reactions associated with sunscreen products and the importance of testing to an expanded series: retrospective analysis of North American Contact Dermatitis Group data, 2001 to 2010. | 21.1 | 0 | 2 |
| Positive patch test reactions to carba mix and iodopropynyl butylcarbamate: data from the North American Contact Dermatitis Group, 1998-2008. | 21.1 | 0 | 2 |
| Occupational contact dermatitis in hairdressers: an analysis of patch test data from the Danish contact dermatitis group, 2002-2011. | 21.1 | 0 | 2 |
| Clinical patch test data evaluated by multivariate analysis. Danish Contact Dermatitis Group | 21.1 | 0 | 2 |
| Exposure data for cosmetic products: facial cleanser, hair conditioner, and eye shadow | 21.1 | 0 | 2 |
| Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment | 21.1 | 0 | 2 |
| Allergic contact dermatitis from pharmaceutical grade BHA in Timodine, with no patch test reaction to analytical grade BHA. | 21.1 | 0 | 2 |
| Allergic patch test reactions associated with cosmetics: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2004. | 21.1 | 0 | 2 |
| Positive patch test reactions to lanolin: cross-sectional data from the north american contact dermatitis group, 1994 to 2006. | 21.1 | 0 | 2 |
| Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data. | 21.1 | 0 | 2 |
| A comparative study of allergic contact dermatitis by patch test versus reflectance confocal laser microscopy, with nickel and cobalt | 21.1 | 0 | 2 |
| Supplementation of flaxseed oil diminishes skin sensitivity and improves skin barrier function and condition | 21.1 | 0 | 2 |
| Common Allergens Identified Based on Patch Test Results in Patients with Suspected Contact Dermatitis of the Scalp. | 21.1 | 0 | 2 |
| Allergic contact dermatitis pattern in Kuwait: nickel leads the pack. In-depth analysis of nickel allergy based on the results from a large prospective patch test series report | 21.1 | 0 | 2 |
| Sensitive Skin: Assessment of the Skin Barrier Using Confocal Raman Microspectroscopy. | 21.1 | 0 | 2 |
| Effect of standardized skin care regimens on neonatal skin barrier function in different body areas | 21.1 | 0 | 2 |
| Occupational contact dermatitis in painters: an analysis of patch test data from the Danish Contact Dermatitis Group | 21.1 | 0 | 2 |
| Occupational allergic contact dermatitis and patch test results of leather workers at two Indonesian tanneries. | 21.1 | 0 | 2 |
| Allergic contact dermatitis to benzocaine: the importance of concomitant positive patch test results | 21.1 | 0 | 2 |
| Validity and ethics of the human 4-h patch test as an alternative method to assess acute skin irritation potential | 21.1 | 0 | 2 |
| Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care | 21.1 | 0 | 2 |
| Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis | 21.1 | 0 | 2 |
| Allergic contact dermatitis from ophthalmic products: can pre-treatment with sodium lauryl sulfate increase patch test sensitivity? | 21.1 | 0 | 2 |
| Skin Irritation to Glass Wool or Continuous Glass Filaments as Observed by a Patch Test among Human Japanese Volunteers | 21.1 | 0 | 2 |
| Toll-like receptor 3 activation is required for normal skin barrier repair following UV damage | 21.1 | 0 | 2 |
| Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation | 21.1 | 0 | 2 |
| Recommendation to increase the test concentration of methylchloroisothiazolinone/methylisothiazolinone in the European baseline patch test series - on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact De | 21.1 | 0 | 2 |
| Evaluation of the histologic characteristics of patch test confirmed allergic contact dermatitis | 21.1 | 0 | 2 |
| In vivo assessment of the effect of a cream containing Avena Rhealba® extract and hyaluronic acid on the restoration of the skin barrier in de-epidermised skin produced with an erbium-YAG laser | 21.1 | 0 | 2 |
| Analysis of skin patch test results and metalloproteinase-2 levels in a patient with contact dermatitis | 21.1 | 0 | 2 |
| Study of irritant contact dermatitis produced by repeat patch test with sodium lauryl sulfate and assessed by visual methods, transepidermal water loss, and laser Doppler velocimetry | 21.1 | 0 | 2 |
| Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair | 21.1 | 0 | 2 |
| Allergic contact dermatitis in 136 children patch tested between 2000 and 2006. | 21.1 | 0 | 2 |
| Patch test standard series recommended by the Brazilian Contact Dermatitis Study Group during the 2006-2011 period | 21.1 | 0 | 2 |
| Patch test results in patients with allergic contact dermatitis in the Podlasie region. | 21.1 | 0 | 2 |
| The effectiveness of a skin care program for the prevention of contact dermatitis in health care workers (the Healthy Hands Project): study protocol for a cluster randomized controlled trial | 21.1 | 0 | 2 |
| Add-on diagnostic tool for allergic contact dermatitis: the strip patch test. | 21.1 | 0 | 2 |
| Contact dermatitis to topical medicaments: a retrospective chart review from the Ottawa Hospital Patch Test Clinic | 21.1 | 0 | 2 |
| Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management | 21.1 | 0 | 2 |
| Recommendation to include methylisothiazolinone in the European baseline patch test series--on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group | 21.1 | 0 | 2 |
| Allergic contact dermatitis caused by cosmetic products | 21.1 | 0 | 2 |
| Patch test results in 542 patients with suspected contact dermatitis in Turkey | 21.1 | 0 | 2 |
| Contact dermatitis after implantable cardiac defibrillator implantation for ventricular tachycardia | 21.1 | 0 | 2 |
| Brief analysis of causes of sensitive skin and advances in evaluation of anti‐allergic activity of cosmetic products | 21.1 | 0 | 2 |
| Occupational Contact Dermatitis: Workers' Compensation Patch Test Results of Portland, Oregon, 2005-2014. | 21.1 | 0 | 2 |
| Efficacy and Tolerability of a Cosmetic Skin Care Product With Trans-4-t-butylcyclohexanol and Licochalcone A in Subjects With Sensitive Skin Prone to Redness and Rosacea | 21.1 | 0 | 2 |
| Survey of Occupational Allergic Contact Dermatitis and Patch Test among Clothing Employees in Beijing. | 21.1 | 0 | 2 |
| IN VIVO EVALUATION OF SKIN IRRITATION POTENTIAL, MELASMA AND SEBUM CONTENT FOLLOWING LONG TERM APPLICATION OF SKIN CARE CREAM IN HEALTHY ADULTS, USING NON-INVASIVE BIOMETROLOGICAL TECHNIQUES | 21.1 | 0 | 2 |
| Skin Barrier Health: Regulation and Repair of the Stratum Corneum and the Role of Over-the-Counter Skin Care | 21.1 | 0 | 2 |
| Exogenous Factors in Skin Barrier Repair | 21.1 | 0 | 2 |
| Efficacy of a Hand Regimen in Skin Barrier Protection in Individuals With Occupational Irritant Contact Dermatitis | 21.1 | 0 | 2 |
| North American Contact Dermatitis Group Patch Test Results 2013-2014. | 21.1 | 0 | 2 |
| Case studies assessing a new skin barrier repair cream for the treatment of atopic dermatitis | 21.1 | 0 | 2 |
| Re "International survey on skin patch test procedures, attitudes and interpretation" L.K. Tanno et al., WAOJ (2016) 9:8. | 21.1 | 0 | 2 |
| Allergic contact dermatitis caused by efinaconazole: positive patch test reactions up to 0.1% pet. | 21.1 | 0 | 2 |
| The Spanish standard patch test series: 2016 update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC). | 21.1 | 0 | 2 |
| Patch test results of the European baseline series among patients with occupational contact dermatitis across Europe - analyses of the European Surveillance System on Contact Allergy network, 2002-2010. | 21.1 | 0 | 2 |
| North American contact dermatitis group patch test results: 2011-2012. | 21.1 | 0 | 2 |
| Tolerability of a Skin Care Regimen Formulated for Acne‐Prone Skin in Children | 21.1 | 0 | 2 |
| Comparison of Marketed Cosmetic Products Constituents with the Antigens Included in Cosmetic-related Patch Test | 21.1 | 0 | 2 |
| A Randomised Controlled Trial to evaluate the effect of a new skin care regimen on skin barrier function in those with podoconiosis in Ethiopia. | 21.1 | 0 | 2 |
| Allergic contact dermatitis from a cream containing Centella asiatica extract | 21.1 | 0 | 2 |
| Patch Test Results from an Occupational and Contact Dermatitis Clinic in a Tertiary Care Hospital of Southern India: A Retrospective Study | 21.1 | 0 | 2 |
| Contact dermatitis due to Centella asiatica | 21.1 | 0 | 2 |
| Semipermeable glove membranes--effects on skin barrier repair following SLS irritation | 21.1 | 0 | 2 |
| Shoe contact dermatitis from dimethyl fumarate: clinical manifestations, patch test results, chemical analysis, and source of exposure. | 21.1 | 0 | 2 |
| Systemic allergic contact dermatitis due to phenylephrine in eyedrops, with a long-lasting allergic patch test reaction | 21.1 | 0 | 2 |
| Ambroxol-induced systemic contact dermatitis confirmed by positive patch test | 21.1 | 0 | 2 |
| Cumulative irritation patch test of sanitary pads on sensitive skin | 21.1 | 0 | 2 |
| Cumulative skin irritation test of sanitary pads in sensitive skin and normal skin population | 21.1 | 0 | 2 |
| Methylchloroisothiazolinone and Methylisothiazolinone Allergic Contact Dermatitis and the Effect of Patch Test Concentration | 21.1 | 0 | 2 |
| Sanitary napkin contact dermatitis of the vulva: location-dependent differences in skin surface conditions may play a role in negative patch test results | 21.1 | 0 | 2 |
| Reduced levels of glutathione S-transferases in patch test reactions to dithranol and sodium lauryl sulphate as demonstrated by quantitative immunocytochemistry: evidence for oxidative stress in acute irritant contact dermatitis | 21.1 | 0 | 2 |
| Patch test results with tixocortol pivalate and budesonide in Germany and Austria | 21.1 | 0 | 2 |
| Combination therapy improves the recovery of the skin barrier function: an experimental model using a contact allergy patch test combined with TEWL measurements | 21.1 | 0 | 2 |
| Late reactions to patch test preparations with reduced concentrations of p-phenylenediamine: a multicentre investigation of the German Contact Dermatitis Research Group | 21.1 | 0 | 2 |
| Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief? | 21.1 | 0 | 2 |
| Short term study of human skin irritation by single application closed patch test: assessment of four multiple emulsion formulations loaded with botanical extracts. | 21.1 | 0 | 2 |
| Population differences in acute skin irritation responses. Race, sex, age, sensitive skin and repeat subject comparisons. | 21.1 | 0 | 2 |
| The profile of patch test reactions to common contact allergens is related to sex. | 21.1 | 0 | 2 |
| Lyral has been included in the patch test standard series in Germany | 21.1 | 0 | 2 |
| P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption | 21.1 | 0 | 2 |
| Common contact sensitizers in the Czech Republic. Patch test results in 12,058 patients with suspected contact dermatitis*. | 21.1 | 0 | 2 |
| Concomitant patch test reactions to mercapto mix and mercaptobenzothiazole: retrospective analysis from the North American Contact Dermatitis Group, 1994-2008. | 21.1 | 0 | 2 |
| Positive patch test reactions in older individuals: Retrospective analysis from the North American Contact Dermatitis Group, 1994-2008 | 21.1 | 0 | 2 |
| Accounting for intended use application in characterizing the contributions of cyclopentasiloxane (D5) to aquatic loadings following personal care product use: Antiperspirants, skin care products and hair care products | 21.1 | 0 | 2 |
| Histologic aspects of patch test reactions in allergic contact dermatitis | 21.1 | 0 | 2 |
| Electroporation and ultradeformable liposomes; human skin barrier repair by phospholipid | 21.1 | 0 | 2 |
| Allergic contact dermatitis due to phenylephrine hydrochloride, with an unusual patch test reaction | 21.1 | 0 | 2 |
| Comparison of patch test contact sensitivity to acetone and aqueous extracts of Parthenium hysterophorus in patients with airborne contact dermatitis | 21.1 | 0 | 2 |
| Effect of semipermeable membranes on skin barrier repair following tape stripping | 21.1 | 0 | 2 |
| Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group | 21.1 | 0 | 2 |
| Patch test results with the metalworking fluid series of the German Contact Dermatitis Research Group (DKG). | 21.1 | 0 | 2 |
| Valdecoxib-induced systemic contact dermatitis confirmed by positive patch test | 21.1 | 0 | 2 |
| Characteristics of patch test reactions to common preservatives incorporated in petrolatum and water, respectively | 21.1 | 0 | 2 |
| The American Academy of Dermatology patch test series for contact dermatitis | 21.1 | 0 | 2 |
| Pesticide patch test series for the assessment of allergic contact dermatitis among banana plantation workers in panama. | 21.1 | 0 | 2 |
| North American Contact Dermatitis Group patch test results for 2007-2008. | 21.1 | 0 | 2 |
| Skin care products can aggravate epidermal function: studies in a murine model suggest a pathogenic role in sensitive skin. | 21.1 | 0 | 2 |
| Scratch-patch test for the diagnosis of allergic contact dermatitis to aciclovir | 21.1 | 0 | 2 |
| The Association of Race/Ethnicity and Patch Test Results: North American Contact Dermatitis Group, 1998-2006. | 21.1 | 0 | 2 |
| Patch Test Reactions to Corticosteroids: Retrospective Analysis From the North American Contact Dermatitis Group 2007-2014. | 21.1 | 0 | 2 |
| Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment | 21.1 | 0 | 2 |
| Comparative assessment of the acute skin irritation potential of detergent formulations using a novel human 4-h patch test method. | 21.1 | 0 | 2 |
| Addendum to Geier J, Lessmann H, Uter W, Schnuch A. Are concomitant patch test reactions to epoxy resin and BIS-GMA indicative of cross reactivity? Contact Dermatitis 2007: 57: 376-380. | 21.1 | 0 | 2 |
| Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000. | 21.1 | 0 | 2 |
| Crude 4-methylcyclohexanemethanol (MCHM) did not cause skin irritation in humans in 48-h patch test. | 21.1 | 0 | 2 |
| Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils | 21.1 | 0 | 2 |
| cosmetic shop | 21.1 | 0 | 2 |
| Analysis of sensitive skin barrier function: basic indicators and sebum composition | 21.1 | 0 | 2 |
| Applying a vernix caseosa based formulation accelerates skin barrier repair by modulating lipid biosynthesis. | 21.1 | 0 | 2 |
| Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment | 21.1 | 0 | 2 |
| Risks of Allergic Contact Dermatitis Elicited by Nickel, Chromium, and Organic Sensitizers: Quantitative Models Based on Clinical Patch Test Data | 21.1 | 0 | 2 |
| Atopy Associated With Positive Patch Test and Possible Allergic Contact Dermatitis | 21.1 | 0 | 2 |
| Examination of the skin barrier repair/wound healing process using a living skin equivalent (LSE) model and matrix-assisted laser desorption-ionization-mass spectrometry imaging (MALDI-MSI). | 21.1 | 0 | 2 |
| The purpuric patch test in patients with allergic contact dermatitis from azo dyes | 21.1 | 0 | 2 |
| Colloidal Oatmeal <em>(Avena Sativa)</em> Improves Skin Barrier Through Multi-Therapy Activity | 21.1 | 0 | 2 |
| Patch test results in schoolchildren. Results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG) | 21.1 | 0 | 2 |
| More positive patch test reactions with larger test chambers? Results from a study group of the German Contact Dermatitis Research Group (DKG). | 21.1 | 0 | 2 |
| Pattern of patch test reactivity among patients with clinical diagnosis of contact dermatitis: a hospital-based study | 21.1 | 0 | 2 |
| Comparison of skin calming effects of cosmetic products containing 4‐t‐butylcyclohexanol or acetyl dipeptide‐1 cetyl ester on capsaicin‐induced facial stinging in volunteers with sensitive skin | 21.1 | 0 | 2 |
| Patch test reactions in children, adults and the elderly. A comparative study in patients with suspected allergic contact dermatitis | 21.1 | 0 | 2 |
| Epicutaneous patch test results in children and adults with allergic contact dermatitis in Karlovac county: a retrospective survey | 21.1 | 0 | 2 |
| Female wet workers and contact dermatitis: patch test results and sensitization in North-East Italy. | 21.1 | 0 | 2 |
| Thoughts on how to improve the quality of multicentre patch test studies | 21.1 | 0 | 2 |
| Clinical expression of nickel contact dermatitis primed by diagnostic patch test. | 21.1 | 0 | 2 |
| The study of human skin irritation of a novel herbal skin care product and ingredients by human single closed patch testing | 21.1 | 0 | 2 |
| Epicutaneous patch test results in patients with allergic contact dermatitis in Karlovac county--a retrospective survey. | 21.1 | 0 | 2 |
| Ceramide analogue 14S24 ((S)-2-tetracosanoylamino-3-hydroxypropionic acid tetradecyl ester) is effective in skin barrier repair in vitro. | 21.1 | 0 | 2 |
| Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair. | 21.1 | 0 | 2 |
| Symmetrical Intertriginous Skin Eruption in a Patient With Positive Patch Test to Metal: Systemic Contact Dermatitis or Lichen Planus Pigmentosus Inversus? | 21.1 | 0 | 2 |
| Clinical, biophysical and immunohistochemical analysis of skin reactions to acute skin barrier disruption - a comparative trial between participants with sensitive skin and those with nonsensitive skin. | 21.1 | 0 | 2 |
| Survey of Patch Test Business Models in the United States by the American Contact Dermatitis Society | 21.1 | 0 | 2 |
| The identification and classification of skin irritation hazard by a human patch test | 21.1 | 0 | 2 |
| The Influence of Two Different Foam Creams on Skin Barrier Repair of Foot Xerosis: A Prospective, Double-Blind, Randomised, Placebo-Controlled Intra-Individual Study | 21.1 | 0 | 2 |
| Patch test reactions to the chinese standard screening allergens in 1,135 patients investigated for allergic contact dermatitis | 21.1 | 0 | 2 |
| Occupational contact dermatitis caused by methylchloroisothiazolinone/methylisothiazolinone through exposure to filler dust containing this preservative and with a positive patch test reaction to the dust. | 21.1 | 0 | 2 |
| Efficacy of the combined use of a facial cleanser and moisturizers for the care of mild acne patients with sensitive skin | 21.1 | 0 | 2 |
| The perceived obstacles in performing patch test to detect allergic contact dermatitis: a comparison between community allergists and directors of allergy training programs | 21.1 | 0 | 2 |
| An ex vivo biochemical model to study the antioxidant clinical properties of cosmetic products in human antiaging skin care | 21.1 | 0 | 2 |
| Results of Hairdressing Series Patch Test in Patients with Allergic Contact Dermatitis to Para-phenylenediamine; Are there any Safe Alternatives? | 21.1 | 0 | 2 |
| Pilot study on a new concept of documenting the clinical relevance of patch test results in contact dermatitis patients | 21.1 | 0 | 2 |
| Sunscreen and facial skin care products in frontal fibrosing alopecia: a case control study | 21.1 | 0 | 2 |
| Statistical analysis plan for the Healthy Hands Project; single centre cluster-randomised clinical trial of a skin care program for the prevention of contact dermatitis in health care workers | 21.1 | 0 | 2 |
| Skin care in occupational contact dermatitis of the hands | 21.1 | 0 | 2 |
| Strip patch test vs. conventional patch test to detect type IV sensitization in patients with allergic contact dermatitis | 21.1 | 0 | 2 |
| To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test | 21.1 | 0 | 2 |
| Assessment of the Efficacy and Barrier Protection of Two Cosmetic Products | 21.1 | 0 | 2 |
| Clinical Analysis of the Influence of Using the Skin Care Products on the Diaper Area in Comparison With Using a Cotton Wool Cloth, Moistened With Clear Water on the Skin Physiology of the Newborns From the 1st Day to the 4th Week of Life | 21.1 | 0 | 2 |
| Lactacyd Radiance (Lactic Acid) Prophetic Patch Test | 21.1 | 0 | 2 |
| Skin Biophysical Parameters and Patch Test Results in People Predisposing to Xiaotong Tiegao Induced Irritant Contact Dermatitis | 21.1 | 0 | 2 |
| Analysis of Epicutaneous Patch Test Results in Patients with Contact Dermatitis | 21.1 | 0 | 2 |
| Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin. | 21.1 | 0 | 2 |
| Cumulative Skin Irritation Potential of a New 25 mg Nicotine Patch | 21.1 | 0 | 2 |
| Comparative Safety Study of New Sinecort Formulation Versus Positive Control | 21.1 | 0 | 2 |
| A 21-Day Study to Evaluate the Skin Irritation Potential of CCP-020 (Diacerein 1%) Topical Ointment in Healthy Subjects Using a Cumulative Irritant Patch Test Design | 21.1 | 0 | 2 |
| Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50 | 21.1 | 0 | 2 |
| Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Dermacontrol Oil Control Moisturizer SPF 30 | 21.1 | 0 | 2 |
| Patch Test Skin Irritation/Sensitization of Cetaphil Daily Advance Ultra Hydration Lotion | 21.1 | 0 | 2 |
| Cumulative Skin Irritation Potential of a New 15 mg Nicotine Patch | 21.1 | 0 | 2 |
| To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products | 21.1 | 0 | 2 |
| To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin | 21.1 | 0 | 2 |
| Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test | 21.1 | 0 | 2 |
| Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body Wash | 21.1 | 0 | 2 |
| An RCT to Evaluate the Effect of a New Skin Care Regimen on SBF in Those With Podoconiosis | 21.1 | 0 | 2 |
| Skin Irritation Study of GSK2894512 Cream | 21.1 | 0 | 2 |
| Evaluation of contact dermatitis using the TRUE patch test | 21.1 | 0 | 2 |
| Skin and laboratory tests: comparison of the epicutaneous patch test with the TTL and LIF tests in the diagnosis of medicamentous allergic contact dermatitis | 21.1 | 0 | 2 |
| Histopathological changes in canine allergic contact dermatitis patch test reactions. A study on spontaneously hypersensitive dogs | 21.1 | 0 | 2 |
| Effects of topically applied glucocorticosteroids on patch test responses and recruitment of inflammatory cells in allergic contact dermatitis | 21.1 | 0 | 2 |
| PUVA treatment of nickel contact dermatitis: effect on dermatitis, patch test sensitivity, and lymphocyte transformation reactivity | 21.1 | 0 | 2 |
| Patch test of mercury compounds and disinfectant solutions and the clinical picture of mercury contact dermatitis | 21.1 | 0 | 2 |
| Validity of patch test screening trays in the evaluation of patients with allergic contact dermatitis | 21.1 | 0 | 2 |
| Result of patch test and allergic contact dermatitis--statistics over the past six years | 21.1 | 0 | 2 |
| Substances most frequently causing contact dermatitis and skin irritation in Poland. I. Cosmetics | 21.1 | 0 | 2 |
| Contact hypersensitivity to corticosteroids in routine patch test patients. A multi-centre study of the Swiss Contact Dermatitis Research Group | 21.1 | 0 | 2 |
| Patch test results in hairdressers with contact dermatitis in Greece (1985-1994) | 21.1 | 0 | 2 |
| Utility objects most frequently causing contact dermatitis and skin irritation in Poland. V. Other products causing eczema | 21.1 | 0 | 2 |
| Allergic contact dermatitis from doxepin cream. One-year patch test clinic experience | 21.1 | 0 | 2 |
| A clinical and patch test study of contact dermatitis from traditional Chinese medicinal materials | 21.1 | 0 | 2 |
| Allergic contact dermatitis from butoxyethyl nicotinic acid and Centella asiatica extract | 21.1 | 0 | 2 |
| Contact dermatitis after calcipotriol and patch test evaluation | 21.1 | 0 | 2 |
| Allergic contact dermatitis due to Centella asiatica: a new case | 21.1 | 0 | 2 |
| An immunohistochemical study on mild skin irritation induced by a single application of a low-molarity sodium dodecyl sulfate solution: keys to the prevention of irritant contact dermatitis | 21.1 | 0 | 2 |
| Evaluation of a human patch test for the identification and classification of skin irritation potential | 21.1 | 0 | 2 |
| Contact dermatitis, patch test response, and pentoxifyline. What conclusions can be drawn at present? | 21.1 | 0 | 2 |
| The patch test in contact dermatitis | 21.1 | 0 | 2 |
| Patch test in contact dermatitis | 21.1 | 0 | 2 |
| Allergic contact dermatitis due to Centella asiatica extract | 21.1 | 0 | 2 |
| Histological distinction between early allergic and irritant patch test reactions: follicular spongiosis may be characteristic of early allergic contact dermatitis | 21.1 | 0 | 2 |
| Allergic contact dermatitis from cobalt in a beauty product | 21.1 | 0 | 2 |
| Thoughts on sensitizers in a standard patch test series. The European Society of Contact Dermatitis | 21.1 | 0 | 2 |
| Interlaboratory evaluation of a human patch test for the identification of skin irritation potential/hazard | 21.1 | 0 | 2 |
| Patch test materials for mercury allergic contact dermatitis | 21.1 | 0 | 2 |
| Allergic contact dermatitis due to eye drops. Their clinical features and the patch test results | 21.1 | 0 | 2 |
| ROLE OF the patch test in contact dermatitis | 21.1 | 0 | 2 |
| lontophoretic Patch Test in Allergic Contact Dermatitis: 30 Years’ Experience | 21.1 | 0 | 2 |
| Application of a 4-h human patch test method for comparative and investigative assessment of skin irritation | 21.1 | 0 | 2 |
| North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens | 21.1 | 0 | 2 |
| Evaluation of skin barrier function in allergic contact dermatitis and atopic dermatitis using method of the continuous TEWL measurement | 21.1 | 0 | 2 |
| Dermal Cumulative Irritant Patch Study | 21.1 | 0 | 2 |
| Systemic contact dermatitis due to norfloxacin with a positive patch test to quinoline mix | 21.1 | 0 | 2 |
| Occupational allergic contact dermatitis in a patient with a positive patch test to tin | 21.1 | 0 | 2 |
| Associated positive patch test reactions to standard contact allergens | 21.1 | 0 | 2 |
| The effect of two moisturisers on skin barrier damage in allergic contact dermatitis | 21.1 | 0 | 2 |
| Allergic contact dermatitis from 5-fluorouracil with positive intradermal test and doubtful patch test reactions | 21.1 | 0 | 2 |
| Reproducibility of irritant patch test reactions to sodium lauryl sulfate in a double-blind placebo-controlled randomized study using clinical scoring. Results from a study group of the German Contact Dermatitis Research Group (Deutsche Kontaktaller | 21.1 | 0 | 2 |
| PHOTO-CONTACT DERMATITIS. THE PHOTO-PATCH TEST AS A VERIFICATION OF THE PHOTO-ALLERGIC NATURE | 21.1 | 0 | 2 |
| Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers | 21.1 | 0 | 2 |
| A high-positive patch test load correlates with further positive patch test reactions irrespective of their location | 21.1 | 0 | 2 |
| Standard patch test results in patients with contact dermatitis in Israel: age and sex differences | 21.1 | 0 | 2 |
| Dynamics of skin barrier repair following topical applications of miconazole nitrate | 21.1 | 0 | 2 |
| Positive patch test reactions to nickel sulphate are not modified by neighbouring negative fragrance patch tests. A multicenter-study by the German contact dermatitis research group | 21.1 | 0 | 2 |
| The effect of a daily facial cleanser for normal to oily skin on the skin barrier of subjects with acne | 21.1 | 0 | 2 |
| European Standard Series patch test results from a contact dermatitis clinic in Israel during the 7-year period from 1998 to 2004 | 21.1 | 0 | 2 |
| Determination of skin irritation potential in the human 4-h patch test | 21.1 | 0 | 2 |
| Case of allergic contact dermatitis due to a topical agent containing chlorpheniramine maleate, with a false-negative patch test | 21.1 | 0 | 2 |
| Positive patch test reaction without clinical contact dermatitis--what is the best approach in medico-legal evaluation? | 21.1 | 0 | 2 |
| Patch test in Chinese patients with cosmetic allergic contact dermatitis to common cosmetic allergens from a European cosmetic series | 21.1 | 0 | 2 |
| Are adverse skin reactions to cosmetics underestimated in the clinical assessment of contact dermatitis? A prospective study among 1075 patients attending Swedish patch test clinics | 21.1 | 0 | 2 |
| Prevalence and 1-year outcome of facial allergic contact dermatitis in patients patch tested in a university hospital | 21.1 | 0 | 2 |
| Allergic contact dermatitis in 191 consecutively patch tested children | 21.1 | 0 | 2 |
| Allergic contact dermatitis and the endocannabinoid system: from mechanisms to skin care | 21.1 | 0 | 2 |
| Strong allergic patch test reactions may indicate a general disposition for contact allergy | 21.1 | 0 | 2 |
| Allergic contact dermatitis caused by sodium dehydroacetate, not hyaluronic acid, in Ialuset® cream | 21.1 | 0 | 2 |
| Dynamics of skin barrier repair following preconditioning by a biotechnology-driven extract from samphire (Crithmum maritimum) stem cells | 21.1 | 0 | 2 |
| Result of standard patch test in patients suspected of having allergic contact dermatitis | 21.1 | 0 | 2 |
| Allergic contact dermatitis caused by tetrahydroxypropyl ethylenediamine in cosmetic products | 21.1 | 0 | 2 |
| The patch test in contact dermatitis | 21.1 | 0 | 2 |
| Patch test results from a contact dermatitis clinic in North India | 21.1 | 0 | 2 |
| Role of the Patch Test in Contact Dermatitis | 21.1 | 0 | 2 |
| New treatments for restoring impaired epidermal barrier permeability: Skin barrier repair creams | 21.1 | 0 | 2 |
| Allergic contact dermatitis from heparin-containing gel: use of scratch patch test for diagnosis | 21.1 | 0 | 2 |
| A retrospective study of patients with facial allergic contact dermatitis patch tested with the European standard series in Turkey | 21.1 | 0 | 2 |
| Evaluation of an onion extract, Centella asiatica, and hyaluronic acid cream in the appearance of striae rubra | 21.1 | 0 | 2 |
| A rare case of allergic contact dermatitis from silver nitrate in a widely used special patch test marker | 21.1 | 0 | 2 |
| Irritant contact dermatitis. Part II. Evaluation evaluation of skin irritation potential of chemicals | 21.1 | 0 | 2 |
| The effect of damaged skin barrier induced by subclinical irritation on the sequential irritant contact dermatitis | 21.1 | 0 | 2 |
| Contact dermatitis caused by a footwear label with a positive patch test reaction to 2‐monomethylol phenol | 21.1 | 0 | 2 |
| Understanding skin care and skin barrier function in infants | 21.1 | 0 | 2 |
| Non‐invasive assessment of tryptophan fluorescence and confocal microscopy provide information on skin barrier repair dynamics beyond TEWL | 21.1 | 0 | 2 |
| An ex vivo human skin model for studying skin barrier repair | 21.1 | 0 | 2 |
| Allergic patch test and contact dermatitis by in vivo reflectance confocal microscopy | 21.1 | 0 | 2 |
| Allergic contact dermatitis caused by undisclosed thiurams in a patch test tubular net | 21.1 | 0 | 2 |
| North American Contact Dermatitis Group patch test results: 2009 to 2010 | 21.1 | 0 | 2 |
| Canadian Consensus on Skin Barrier Repair Therapy in Atopic Dermatitis | 21.1 | 0 | 2 |
| Elevation of IL-9 in Extreme Patch Test Reactions Suggests It Is an Inflammatory Mediator in Allergic Contact Dermatitis | 21.1 | 0 | 2 |
| Limonene hydroperoxide analogues show specific patch test reactions | 21.1 | 0 | 2 |
| Patch test results of the dental personnel with contact dermatitis | 21.1 | 0 | 2 |
| Effects of washing of the face with a mild facial cleanser formulated with sodium laureth carboxylate and alkyl carboxylates on acne in Japanese adult males | 21.1 | 0 | 2 |
| The effects of benzylsulfonyl-D-Ser-homoPhe-(4-amidino-benzylamide), a dual plasmin and urokinase inhibitor, on facial skin barrier function in subjects with sensitive skin | 21.1 | 0 | 2 |
| Allergic contact dermatitis caused by (meth)acrylates in nail cosmetic products in users and nail technicians - a 5-year study | 21.1 | 0 | 2 |
| Food-Related Contact Dermatitis, Contact Urticaria, and Atopy Patch Test with Food | 21.1 | 0 | 2 |
| The role of skin barrier in occupational contact dermatitis | 21.1 | 0 | 2 |
| Pediatric Baseline Patch Test Series: Pediatric Contact Dermatitis Workgroup | 21.1 | 0 | 2 |
| Improving the Diagnosis of Allergic Contact Dermatitis Using Patch Test With Gloves | 21.1 | 0 | 2 |
| [Prediction of occupational allergic contact dermatitis induced by formaldehyde by IL17/IL22 secretion cell rest combined with patch test] | 21.1 | 0 | 2 |
| Compromising human skin in vivo and ex vivo to study skin barrier repair | 21.1 | 0 | 2 |
| Occupational contact dermatitis in Triveneto: Analysis of patch test data of the North Eastern Italian Database from 1996 to 2016 | 21.1 | 0 | 2 |
| Tertiary prevention of occupational skin diseases: Prevalence of allergic contact dermatitis and pattern of patch test results | 21.1 | 0 | 2 |
| Natural Does Not Mean Safe-The Dirt on Clean Beauty Products | 21.1 | 0 | 2 |
| Comparative assessment of 24-hr primary skin irritation test and human patch test data with in vitro skin irritation tests according to OECD Test Guideline 439 (for quasi-drugs in Japan) | 21.1 | 0 | 2 |
| Pumpkin seeds, Centella asiatica, Boswellia, Helichrysum, acetate vitamin E, Melaleuca alternifolia and hyaluronic acid phytocomplex monotherapy effects in patients with chronic pelvic pain syndrome | 21.1 | 0 | 2 |
| The effect of anti-IL-17 treatment on the reaction to a nickel patch test in patients with allergic contact dermatitis | 21.1 | 0 | 2 |
| Patch Test Practice Patterns of Members of the American Contact Dermatitis Society | 21.1 | 0 | 2 |
| Commentary on JAMA Dermatology Editorial: "Natural Does Not Mean Safe-The Dirt on Clean Beauty Products" | 21.1 | 0 | 2 |
| Effectiveness of a skin care programme for the prevention of contact dermatitis in healthcare workers (the Healthy Hands Project): A single-centre, cluster randomized controlled trial | 21.1 | 0 | 2 |
| Evaluation of skin irritation potentials of different cosmetic products in Turkish market by reconstructed human epidermis model | 21.1 | 0 | 2 |
| The Spectrum of Sensitive Skin: Considerations for Skin Care in Vulnerable Populations | 21.1 | 0 | 2 |
| Twenty-eight-day follow-up of patch test reactions to p-phenylenediamine and p-phenylenediamine dihydrochloride: A multicentre study on behalf of the European Environmental and Contact Dermatitis Research Group | 21.1 | 0 | 2 |
| Pigmented Facial Contact Dermatitis to Benzyl Salicylate: A Comparative Histopathological and Immunohistochemical Study of the Involved Skin and the Positive Patch Test Site | 21.1 | 0 | 2 |
| Clinicoepidemiological and Patch Test Profile of Patients Attending the Contact Dermatitis Clinic of a Tertiary Care Hospital in North India: A 7-Year Retrospective Study | 21.1 | 0 | 2 |
| A seven-year retrospective analysis of patch test data in a cohort of patients with contact dermatitis in Sri Lanka | 21.1 | 0 | 2 |
| Dermal targeting of Centella asiatica extract using hyaluronic acid surface modified niosomes | 21.1 | 0 | 2 |
| Clinical and in vitro evaluation of new anti-redness cosmetic products in subjects with winter xerosis and sensitive skin | 21.1 | 0 | 2 |
| [Sensitive skin, reactive skin] | 21.1 | 0 | 2 |
| Comparison of transepidermal water loss rates in subjects with skin patch test positive vs negative to skin care products | 21.1 | 0 | 2 |
| [Function of Sacran as an Artificial Skin Barrier and the Development of Skincare Products] | 21.1 | 0 | 2 |
| Modulators of the endocannabinoid system influence skin barrier repair, epidermal proliferation, differentiation and inflammation in a mouse model | 21.1 | 0 | 2 |
| First case of contact dermatitis caused by C12-13 alkyl malate used in a skin care product for acne | 21.1 | 0 | 2 |
| Human T cell response to CD1a and contact dermatitis allergens in botanical extracts and commercial skin care products | 21.1 | 0 | 2 |
| Exploratory study to evaluate two clinical methods for assessing moisturizing effect on skin barrier repair | 21.1 | 0 | 2 |
| North American Contact Dermatitis Group Patch Test Results: 2015-2016 | 21.1 | 0 | 2 |
| Allergic contact dermatitis to methylisothiazolinone in hair care products: report of a case | 21.1 | 0 | 2 |
| Practical approaches to skin barrier recovery and maintenance: principles of cleansing for children and adults | 21.1 | 0 | 2 |
| Skin irritation and sensitization of swine acellular dermal matrix treated with hyaluronic acid | 21.1 | 0 | 2 |
| Effects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties | 21.1 | 0 | 2 |
| beauty store | 21.1 | 0 | 2 |
| Contact dermatitis caused by glucose sensors - 15 adult patients tested with a medical device patch test series | 21.1 | 0 | 2 |
| European Standard Series Patch Test Results in Contact Dermatitis Patients in a Tertiary Care Hospital | 21.1 | 0 | 2 |
| Topical application of autophagy activating peptide improved skin barrier function and reduced acne symptoms in acne-prone skin | 21.1 | 0 | 2 |
| A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations. | 21.1 | 0 | 2 |
| Optical coherence tomography for patch test grading: a prospective study on its use for non-invasive diagnosis of allergic contact dermatitis | 21.1 | 0 | 2 |
| Continuous glucose monitoring systems give contact dermatitis in children and adults despite efforts of providing less "allergy- prone" devices Investigation and advice hampered by insufficient material for optimized patch test investigations | 21.1 | 0 | 2 |
| The Utility of an Occupational Contact Dermatitis Patch Test Database in the Analysis of Workplace Prevention Activities in Toronto, Canada | 21.1 | 0 | 2 |
| Role of Antimicrobial Peptides in Skin Barrier Repair in Individuals with Atopic Dermatitis | 21.1 | 0 | 2 |
| Currently Relevant P-Phenylenediamine Patch Test Reactions Associated with Hair Dye and Non-Scalp Anatomic Areas: Retrospective Cross-Sectional Analysis of North American Contact Dermatitis Group Data, 2001 to 2016 | 21.1 | 0 | 2 |
| Positive Patch Test Reactions to Carba Mix and Thiuram Mix: The North American Contact Dermatitis Group Experience (1994-2016) | 21.1 | 0 | 2 |
| Can We Separate Oral Lichen Planus from Allergic Contact Dermatitis and Should We Patch Test? A Systematic Review of Chronic Oral Lichenoid Lesions | 21.1 | 0 | 2 |
| Preparation and characterization of collagen/chitosan/hyaluronic acid thin films for application in hair care cosmetics | 21.1 | 0 | 2 |
| A 96-hour Patch Test Study Using Healthy Human Volunteers to Assess the Skin Irritation Potential of 11 Topically Applied Formulations | 21.1 | 0 | 2 |
| Patch test informed consent form: position statement by European Academy of Dermatology and Venereology Task Force on Contact Dermatitis | 21.1 | 0 | 2 |
| 50 Human Subject Repeat Insult Patch Test | 21.1 | 0 | 2 |
| Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test) | 21.1 | 0 | 2 |
| Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test) | 21.1 | 0 | 2 |
| Evaluating the gentleness of a new professional model sonic skin care brush though non-invasive measurements of the skin barrier | 21.1 | 0 | 2 |
| WATER'S EDGE DERMATOLOGY | 21.1 | 0 | 2 |
| Mecca | 21.1 | 0 | 2 |
| A Study on the Beauty Action of the High-School Girl with the Beauty, Beauty Products, and Multi-function Beauty Product Interest | 21.1 | 0 | 2 |
| Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers | 21.1 | 0 | 2 |
| Patch Test Results in Patients with Suspected Contact Dermatitis at a Tertiary Care Hospital in a Semiurban Area in Rajasthan: A Cross-sectional Study | 21.1 | 0 | 2 |
| Etiology of Allergic Contact Dermatitis based on Patch Test | 21.1 | 0 | 2 |
| Patch Test Results in 169 Patients with Allergic Contact Dermatitis in Malatya | 21.1 | 0 | 2 |
| Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019–2020 | 21.1 | 0 | 2 |
| Promoting a Healthy Skin Barrier Using Skin Care in People With Mature Skin Xerosis | 21.1 | 0 | 2 |
| Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device | 21.1 | 0 | 2 |
| Allergic contact dermatitis caused by acrylates in nail cosmetic products: Case reports and review of the literatures | 21.1 | 0 | 2 |
| 682 Induction of keratin 1 and keratin 10 expression by topical glucose in a mouse model of atopic dermatitis and in keratinocyte culture: A possible role of glucose in skin barrier repair | 21.1 | 0 | 2 |
| 674 TRPV1 positive peripheral sensory nerves are required for prompt skin barrier repair | 21.1 | 0 | 2 |
| Konga Health | 21.1 | 0 | 2 |
| cosmetic shop chain | 21.1 | 0 | 2 |
| Q135293930 | 21.1 | 0 | 2 |
| Q137176402 | 21.1 | 0 | 2 |
| Mon Platin Professional | 21.1 | 0 | 2 |
| PowerV | 21.1 | 0 | 2 |
| Nordstrom | 20.0 | 1 | 0 |
| United States Food and Drug Administration | 20.0 | 1 | 0 |
| Q229883 | 20.0 | 1 | 0 |
| Bloomingdale's | 20.0 | 1 | 0 |
| Harrods | 20.0 | 1 | 0 |
| Q483551 | 20.0 | 1 | 0 |
| Baidu Baike | 20.0 | 1 | 0 |
| Dateline NBC | 20.0 | 1 | 0 |
| Meet the Press | 20.0 | 1 | 0 |
| Walgreens | 20.0 | 1 | 0 |
| Whole Foods Market | 20.0 | 1 | 0 |
| CVS Pharmacy | 20.0 | 1 | 0 |
| Voice of Tibet | 20.0 | 1 | 0 |
| Clinique Laboratories, LLC | 20.0 | 1 | 0 |
| NBC News | 20.0 | 1 | 0 |
| WebMD | 20.0 | 1 | 0 |
| 5W Public Relations | 20.0 | 1 | 0 |
| ArrayTrack | 20.0 | 1 | 0 |
| Aveda | 20.0 | 1 | 0 |
| Bad Bug Book | 20.0 | 1 | 0 |
| Boots Opticians | 20.0 | 1 | 0 |
| BuzzFeed | 20.0 | 1 | 0 |
| Center for Biologics Evaluation and Research | 20.0 | 1 | 0 |
| Center for Devices and Radiological Health | 20.0 | 1 | 0 |
| Center for Food Safety and Applied Nutrition | 20.0 | 1 | 0 |
| Center for Tobacco Products | 20.0 | 1 | 0 |
| Center for Veterinary Medicine | 20.0 | 1 | 0 |
| Dr. Hauschka | 20.0 | 1 | 0 |
| drugstore.com | 20.0 | 1 | 0 |
| Free People | 20.0 | 1 | 0 |
| Hoda Kotb | 20.0 | 1 | 0 |
| Hooked: Muscle Women | 20.0 | 1 | 0 |
| Boots | 20.0 | 1 | 0 |
| National Center for Toxicological Research | 20.0 | 1 | 0 |
| Office of Criminal Investigations | 20.0 | 1 | 0 |
| CityLink Red | 20.0 | 1 | 0 |
| SkinCeuticals | 20.0 | 1 | 0 |
| Skin Cancer Foundation | 20.0 | 1 | 0 |
| list of Walmart brands | 20.0 | 1 | 0 |
| Bioderma | 20.0 | 1 | 0 |
| Who, What, Wear | 20.0 | 1 | 0 |
| Healthline | 20.0 | 1 | 0 |
| Beauty Brands | 20.0 | 1 | 0 |
| Dermalogica Inc. | 20.0 | 1 | 0 |
| The Honest Company | 20.0 | 1 | 0 |
| BuzzFeed Japan | 20.0 | 1 | 0 |
| NBC Out | 20.0 | 1 | 0 |
| Another Round | 20.0 | 1 | 0 |
| FDA medical bulletin : important information for health professionals from the U.S. Food & Drug Administration | 20.0 | 1 | 0 |
| Well.ca | 20.0 | 1 | 0 |
| National Eczema Association | 20.0 | 1 | 0 |
| cosmetics | 13.3 | 0 | 1 |
| shampoo | 13.3 | 0 | 1 |
| Clearasil | 13.3 | 0 | 1 |
| irritant diaper dermatitis | 13.3 | 0 | 1 |
| irritant contact dermatitis due to oils and greases | 13.3 | 0 | 1 |
| Centella asiatica | 13.3 | 0 | 1 |
| hyaluronic acid | 13.3 | 0 | 1 |
| Sunsilk | 13.3 | 0 | 1 |
| photodermatitis | 13.3 | 0 | 1 |
| Weleda | 13.3 | 0 | 1 |
| contact dermatitis | 13.3 | 0 | 1 |
| toner | 13.3 | 0 | 1 |
| Calgon | 13.3 | 0 | 1 |
| BIPA | 13.3 | 0 | 1 |
| personal lubricant | 13.3 | 0 | 1 |
| Cosmopolitan Cosmetics | 13.3 | 0 | 1 |
| hair conditioner | 13.3 | 0 | 1 |
| chromium allergic contact dermatitis | 13.3 | 0 | 1 |
| beauty salon | 13.3 | 0 | 1 |
| skin care | 13.3 | 0 | 1 |
| patch test | 13.3 | 0 | 1 |
| Centella | 13.3 | 0 | 1 |
| Pantene | 13.3 | 0 | 1 |
| Revlon | 13.3 | 0 | 1 |
| hairbrush | 13.3 | 0 | 1 |
| Import Parfumerie | 13.3 | 0 | 1 |
| Patch test | 13.3 | 0 | 1 |
| Cosmetics Directive | 13.3 | 0 | 1 |
| occupational dermatitis | 13.3 | 0 | 1 |
| Biotherm | 13.3 | 0 | 1 |
| kangaroo care | 13.3 | 0 | 1 |
| Make-up Art Cosmetics | 13.3 | 0 | 1 |
| Contact Dermatitis | 13.3 | 0 | 1 |
| Artistry | 13.3 | 0 | 1 |
| Bumble and bumble | 13.3 | 0 | 1 |
| Natura Cosméticos S.A. | 13.3 | 0 | 1 |
| Hyaluronan sodium | 13.3 | 0 | 1 |
| Schobrunn | 13.3 | 0 | 1 |
| hair care | 13.3 | 0 | 1 |
| Clairol | 13.3 | 0 | 1 |
| Elvive | 13.3 | 0 | 1 |
| Kiko Milano | 13.3 | 0 | 1 |
| NARS Cosmetics | 13.3 | 0 | 1 |
| Q4044353 | 13.3 | 0 | 1 |
| Aesop | 13.3 | 0 | 1 |
| Airbag dermatitis | 13.3 | 0 | 1 |
| Aquaphor | 13.3 | 0 | 1 |
| Avlon Industries | 13.3 | 0 | 1 |
| Bronner Bros. | 13.3 | 0 | 1 |
| Clarisonic | 13.3 | 0 | 1 |
| Conair Corporation | 13.3 | 0 | 1 |
| Cosmetics advertising | 13.3 | 0 | 1 |
| anti-aging cream | 13.3 | 0 | 1 |
| Ella Baché | 13.3 | 0 | 1 |
| Freederm | 13.3 | 0 | 1 |
| Gold Bond | 13.3 | 0 | 1 |
| Good Hair Day | 13.3 | 0 | 1 |
| hairstyling tool | 13.3 | 0 | 1 |
| local lymph node assay | 13.3 | 0 | 1 |
| Marjorie Joyner | 13.3 | 0 | 1 |
| mineral make-up | 13.3 | 0 | 1 |
| Natural skin care | 13.3 | 0 | 1 |
| New Clicks Holdings Limited | 13.3 | 0 | 1 |
| Parachute | 13.3 | 0 | 1 |
| Pond's Creams | 13.3 | 0 | 1 |
| Priceline | 13.3 | 0 | 1 |
| Protein contact dermatitis | 13.3 | 0 | 1 |
| Psssssst | 13.3 | 0 | 1 |
| Redken | 13.3 | 0 | 1 |
| Rusk | 13.3 | 0 | 1 |
| Salon Selectives | 13.3 | 0 | 1 |
| Sensitive Skin | 13.3 | 0 | 1 |
| Sensitive Skin Magazine | 13.3 | 0 | 1 |
| Sensitive skin | 13.3 | 0 | 1 |
| Sensitive skin | 13.3 | 0 | 1 |
| Sensitive skin type | 13.3 | 0 | 1 |
| Category:Skin care | 13.3 | 0 | 1 |
| Superdrug | 13.3 | 0 | 1 |
| Trade Secrets | 13.3 | 0 | 1 |
| toxicodendron dermatitis | 13.3 | 0 | 1 |
| Vie at Home | 13.3 | 0 | 1 |
| Category:Contact dermatitis | 13.3 | 0 | 1 |
| Category:Hair care equipment | 13.3 | 0 | 1 |
| Category:Hair care | 13.3 | 0 | 1 |
| Category:Hair care products | 13.3 | 0 | 1 |
| hair care device | 13.3 | 0 | 1 |
| ingredient list | 13.3 | 0 | 1 |
| Kicks | 13.3 | 0 | 1 |
| MA CHÉRIE | 13.3 | 0 | 1 |
| OXY | 13.3 | 0 | 1 |
| EMERON | 13.3 | 0 | 1 |
| bath additive | 13.3 | 0 | 1 |
| Hada Labo | 13.3 | 0 | 1 |
| Cidesco | 13.3 | 0 | 1 |
| viscosupplementation | 13.3 | 0 | 1 |
| allergic contact dermatitis | 13.3 | 0 | 1 |
| cosmetics industry | 13.3 | 0 | 1 |
| Mannings | 13.3 | 0 | 1 |
| hyaluronic acid binding | 13.3 | 0 | 1 |
| glycosaminoglycan metabolic process | 13.3 | 0 | 1 |
| hyaluronan metabolic process | 13.3 | 0 | 1 |
| hyaluronan catabolic process | 13.3 | 0 | 1 |
| establishment of skin barrier | 13.3 | 0 | 1 |
| hyaluronan biosynthetic process | 13.3 | 0 | 1 |
| Pechoin | 13.3 | 0 | 1 |
| YSL Beauty | 13.3 | 0 | 1 |
| nickel allergic contact dermatitis | 13.3 | 0 | 1 |
| Hunan hand syndrome | 13.3 | 0 | 1 |
| Birchbox | 13.3 | 0 | 1 |
| KORA Organics | 13.3 | 0 | 1 |
| Semichem | 13.3 | 0 | 1 |
| Nardo's Natural | 13.3 | 0 | 1 |
| Rachel K | 13.3 | 0 | 1 |
| Sensitive Skin | 13.3 | 0 | 1 |
| Johnson's Baby | 13.3 | 0 | 1 |
| Habp4 | 13.3 | 0 | 1 |
| Habp2 | 13.3 | 0 | 1 |
| Gm7770 | 13.3 | 0 | 1 |
| Gm3318 | 13.3 | 0 | 1 |
| Ch. Surender Singh Memorial Herbal Park, Tosham | 13.3 | 0 | 1 |
| allergic contact dermatitis of eyelid | 13.3 | 0 | 1 |
| contact dermatitis due to arnica | 13.3 | 0 | 1 |
| Zoe Foster Blake | 13.3 | 0 | 1 |
| Skin care | 13.3 | 0 | 1 |
| Hyaluronan binding protein 2 | 13.3 | 0 | 1 |
| epidermal lamellar body | 13.3 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 13.3 | 0 | 1 |
| Stabilin 2 | 13.3 | 0 | 1 |
| Hyaluronan synthase 1 | 13.3 | 0 | 1 |
| Hyaluronan synthase 2 | 13.3 | 0 | 1 |
| Hyaluronan mediated motility receptor | 13.3 | 0 | 1 |
| Hyaluronan synthase 3 | 13.3 | 0 | 1 |
| Contact dermatitis and other skin conditions in instrumental musicians | 13.3 | 0 | 1 |
| Alstonia scholaris R. Br. Significantly Inhibits Retinoid-Induced Skin Irritation In Vitro and In Vivo | 13.3 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 13.3 | 0 | 1 |
| Hyaluronic acid binding protein 2 | 13.3 | 0 | 1 |
| Hyaluronic acid binding protein 4 | 13.3 | 0 | 1 |
| Hydrocotyle asiatica | 13.3 | 0 | 1 |
| Hyaluronan mediated motility receptor (RHAMM) | 13.3 | 0 | 1 |
| Hyaluronan synthase 3 | 13.3 | 0 | 1 |
| Hyaluronan synthase 2 | 13.3 | 0 | 1 |
| Hyaluronan synthase 1 | 13.3 | 0 | 1 |
| Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators | 13.3 | 0 | 1 |
| Nykaa | 13.3 | 0 | 1 |
| Aveeno Baby product line | 13.3 | 0 | 1 |
| EOS Products, LLC | 13.3 | 0 | 1 |
| Industrial contact dermatitis: effect of the riot control agent ortho-chlorobenzylidene malononitrile | 13.3 | 0 | 1 |
| Insights into the quantitative relationship between sensitization and challenge for allergic contact dermatitis reactions | 13.3 | 0 | 1 |
| Dissolution of cemented carbide powders in artificial sweat: implications for cobalt sensitization and contact dermatitis | 13.3 | 0 | 1 |
| The public health impact of irritant contact dermatitis | 13.3 | 0 | 1 |
| Allergic contact dermatitis from triglycidyl isocyanurate in polyester paint pigments | 13.3 | 0 | 1 |
| Contact dermatitis from B. subtitliss-derived protease enzymes | 13.3 | 0 | 1 |
| Hyaluronic acid binding ability of human sperm reflects cellular maturity and fertilizing potential: selection of sperm for intracytoplasmic sperm injection | 13.3 | 0 | 1 |
| Occupational contact dermatitis in the UK: a surveillance report from EPIDERM and OPRA | 13.3 | 0 | 1 |
| A robust structure-activity relationship (SAR) model for esters that cause skin irritation in humans | 13.3 | 0 | 1 |
| The pattern of tyrosine phosphorylation in human sperm in response to binding to zona pellucida or hyaluronic acid | 13.3 | 0 | 1 |
| Acute stress modulates the irritant component of sensitizers in allergic contact dermatitis: implications for exposure assessment | 13.3 | 0 | 1 |
| Restraint-induced modulation of allergic and irritant contact dermatitis in male and female B6.129 mice | 13.3 | 0 | 1 |
| Concentrations and stability of methyl methacrylate, glutaraldehyde, formaldehyde and nickel sulfate in commercial patch test allergen preparations | 13.3 | 0 | 1 |
| Thiurams in shoe contact dermatitis - a case series | 13.3 | 0 | 1 |
| Noninvasive evaluation of allergic and irritant contact dermatitis by in vivo reflectance confocal microscopy | 13.3 | 0 | 1 |
| Irritant contact dermatitis among health care workers | 13.3 | 0 | 1 |
| Hyaluronic acid binding by human sperm indicates cellular maturity, viability, and unreacted acrosomal status. | 13.3 | 0 | 1 |
| Restraint stress applied prior to chemical sensitization modulates the development of allergic contact dermatitis differently than restraint prior to challenge | 13.3 | 0 | 1 |
| Contact dermatitis and workers' compensation: criteria for establishing occupational causation and aggravation | 13.3 | 0 | 1 |
| Chemical activation of innate and specific immunity in contact dermatitis | 13.3 | 0 | 1 |
| Confocal histopathology of irritant contact dermatitis in vivo and the impact of skin color (black vs white) | 13.3 | 0 | 1 |
| Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle | 13.3 | 0 | 1 |
| AG Hair Care | 13.3 | 0 | 1 |
| Hypoallergenic formula milk versus cow's milk for prevention of wheeze and asthma in children with a family history of atopy | 13.3 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 13.3 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 13.3 | 0 | 1 |
| Chlorhexidine skin care for the prevention of infection in term neonates | 13.3 | 0 | 1 |
| Hyaluronic Acid inclusion in embryo transfer media for assisted reproductive technologies | 13.3 | 0 | 1 |
| Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease | 13.3 | 0 | 1 |
| Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing | 13.3 | 0 | 1 |
| Lipoxygenases mediate the effect of essential fatty acid in skin barrier formation: a proposed role in releasing omega-hydroxyceramide for construction of the corneocyte lipid envelope | 13.3 | 0 | 1 |
| TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation | 13.3 | 0 | 1 |
| Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2 | 13.3 | 0 | 1 |
| The expression of epidermal lipoxygenases and transglutaminase-1 is perturbed by NIPAL4 mutations: indications of a common metabolic pathway essential for skin barrier homeostasis | 13.3 | 0 | 1 |
| CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2 | 13.3 | 0 | 1 |
| Evaluation of the sensitization potential of two lubricant additives, phenyl-alpha-naphthylamine and alkylated phenyl-alpha-naph | 13.3 | 0 | 1 |
| Hyaluronic acid in human articular cartilage. Age-related changes in content and size | 13.3 | 0 | 1 |
| Early inflammatory markers in elicitation of allergic contact dermatitis | 13.3 | 0 | 1 |
| Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier | 13.3 | 0 | 1 |
| A coarse-grained molecular model for glycosaminoglycans: application to chondroitin, chondroitin sulfate, and hyaluronic acid. | 13.3 | 0 | 1 |
| Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid | 13.3 | 0 | 1 |
| Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci | 13.3 | 0 | 1 |
| Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection | 13.3 | 0 | 1 |
| Randomized, controlled trial evaluating a baby wash product on skin barrier function in healthy, term neonates | 13.3 | 0 | 1 |
| Population-Based Inorganic Mercury Biomonitoring and the Identification of Skin Care Products as a Source of Exposure in New York City | 13.3 | 0 | 1 |
| Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4 | 13.3 | 0 | 1 |
| Use of hyaluronic acid fillers for the treatment of the aging face | 13.3 | 0 | 1 |
| Tropic Skin Care | 13.3 | 0 | 1 |
| Identification of hyaluronic acid binding sites in the extracellular domain of CD44 | 13.3 | 0 | 1 |
| Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight | 13.3 | 0 | 1 |
| THE HYDROLYSIS OF HYALURONIC ACID BY BACTERIAL ENZYMES | 13.3 | 0 | 1 |
| Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis | 13.3 | 0 | 1 |
| Fertility testing and ICSI sperm selection by hyaluronic acid binding: clinical and genetic aspects | 13.3 | 0 | 1 |
| Reflectance confocal microscopy may differentiate acute allergic and irritant contact dermatitis in vivo | 13.3 | 0 | 1 |
| Molecular mechanism of skin irritation after acute exposure to m-xylene in rats and guinea pigs | 13.3 | 0 | 1 |
| Intracellular hyaluronic acid binding protein | 13.3 | 0 | 1 |
| Two cases of occupational allergic contact dermatitis from a cycloaliphatic epoxy resin in a neat oil: case report | 13.3 | 0 | 1 |
| Impact on the quality of life of lymphoedema patients following introduction of a hygiene and skin care regimen in a Guyanese community endemic for lymphatic filariasis: A preliminary clinical intervention study | 13.3 | 0 | 1 |
| Cumulus expansion, nuclear maturation and connexin 43, cyclooxygenase-2 and FSH receptor mRNA expression in equine cumulus-oocyte complexes cultured in vitro in the presence of FSH and precursors for hyaluronic acid synthesis | 13.3 | 0 | 1 |
| Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis | 13.3 | 0 | 1 |
| Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action | 13.3 | 0 | 1 |
| The ugly side of beauty products | 13.3 | 0 | 1 |
| Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus | 13.3 | 0 | 1 |
| Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis | 13.3 | 0 | 1 |
| Health hazard evaluation report: HETA-2007-0261-3122, evaluation of contact dermatitis among ink ribbon manufacturing employees - New York | 13.3 | 0 | 1 |
| Comparison of glove contact allergen content and clinical patch test | 13.3 | 0 | 1 |
| Tangle Teezer | 13.3 | 0 | 1 |
| Local lymph node assay as a quantitative risk assessment tool to model biologic skin response of allergic contact dermatitis in the mouse | 13.3 | 0 | 1 |
| Development of new QSAR approaches in occupational contact dermatitis | 13.3 | 0 | 1 |
| Prediction of molecular mechanism of skin irritation after acute exposure to sodium lauryl sulfate | 13.3 | 0 | 1 |
| Winter season, frequent hand washing, and irritant patch test reactions to detergents are associated with hand dermatitis in health care workers | 13.3 | 0 | 1 |
| QSAR models of allergic contact dermatitis | 13.3 | 0 | 1 |
| Health hazard evaluation report: HETA-2006-0155-3072, evaluation of contact dermatitis among machinists at an automotive parts manufacturer, Dana Corporation, Bristol, Virginia | 13.3 | 0 | 1 |
| Cleanser-induced effects on skin barrier function | 13.3 | 0 | 1 |
| A structure-activity relationship (SAR) model for esters that cause human skin irritation | 13.3 | 0 | 1 |
| Workshop on irritant contact dermatitis | 13.3 | 0 | 1 |
| The effect of restraint on the development of allergic contact dermatitis is dependent upon the timing of the restraint | 13.3 | 0 | 1 |
| A study of allergic contact dermatitis caused by chrysanthemums -- characterization of allergens by skin tests on growers and sensitized guinea pigs | 13.3 | 0 | 1 |
| Restraint stress differentially affects cytokine production and ear swelling in allergic contact dermatitis (ACD) and irritant contact dermatitis (ICD) | 13.3 | 0 | 1 |
| Contact dermatitis in a plant that produces polyvinyl chloride compound | 13.3 | 0 | 1 |
| Allergic Contact Dermatitis From Ultraviolet Cured Inks | 13.3 | 0 | 1 |
| The role of antioxidants in skin immune reactions: the use of flow cytometry to determine alterations in Ia-positive epidermal cells in allergic contact dermatitis | 13.3 | 0 | 1 |
| Notes from the field: respiratory symptoms and skin irritation among hospital workers using a new disinfection product - Pennsylvania, 2015 | 13.3 | 0 | 1 |
| Contact dermatitis from use or misuse of soaps, detergents, and cleansers in the workplace | 13.3 | 0 | 1 |
| The epidemiology of occupational contact-dermatitis | 13.3 | 0 | 1 |
| Dressings and topical agents containing hyaluronic acid for chronic wound healing | 13.3 | 0 | 1 |
| Utility of the Atopy Patch Test in the Diagnosis of Allergic Rhinitis | 13.3 | 0 | 1 |
| Recent Updates in Neuroprotective and Neuroregenerative Potential of Centella asiatica | 13.3 | 0 | 1 |
| Genetic basis for hyper production of hyaluronic acid in natural and engineered microorganisms | 13.3 | 0 | 1 |
| Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies | 13.3 | 0 | 1 |
| Clinical evidence in the treatment of rotator cuff tears with hyaluronic acid | 13.3 | 0 | 1 |
| Hyaluronic acid and tendon lesions | 13.3 | 0 | 1 |
| Systemic contact dermatitis | 13.3 | 0 | 1 |
| Possible Immune Regulation of Natural Killer T Cells in a Murine Model of Metal Ion-Induced Allergic Contact Dermatitis | 13.3 | 0 | 1 |
| Delayed-type Necrosis after Soft-tissue Augmentation with Hyaluronic Acid | 13.3 | 0 | 1 |
| The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review | 13.3 | 0 | 1 |
| Microspectroscopic Confocal Raman and Macroscopic Biophysical Measurements in the in vivo Assessment of the Skin Barrier: Perspective for Dermatology and Cosmetic Sciences | 13.3 | 0 | 1 |
| Glans Penis Augmentation Using Hyaluronic Acid Gel as an Injectable Filler | 13.3 | 0 | 1 |
| Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis? | 13.3 | 0 | 1 |
| Skin care: Historical and contemporary views | 13.3 | 0 | 1 |
| Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis | 13.3 | 0 | 1 |
| Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid | 13.3 | 0 | 1 |
| Systematic Review for Effectiveness of Hyaluronic Acid in the Treatment of Severe Degenerative Joint Disease (DJD) of the Knee | 13.3 | 0 | 1 |
| State-of-the-Art management of knee osteoarthritis | 13.3 | 0 | 1 |
| Coacervate delivery systems for proteins and small molecule drugs | 13.3 | 0 | 1 |
| Managing knee ostheoarthritis: efficacy of hyaluronic acid injections | 13.3 | 0 | 1 |
| Hyaluronic Acid and Wound Healing | 13.3 | 0 | 1 |
| Hyaluronic acid hydrogels for vocal fold wound healing | 13.3 | 0 | 1 |
| The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review | 13.3 | 0 | 1 |
| The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection | 13.3 | 0 | 1 |
| Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis | 13.3 | 0 | 1 |
| U.K. standards of care for occupational contact dermatitis and occupational contact urticaria | 13.3 | 0 | 1 |
| Drug Reaction, Skin Care, Skin Loss | 13.3 | 0 | 1 |
| Hyaluronic Acid: from biochemical characteristics to its clinical translation in assessment of liver fibrosis | 13.3 | 0 | 1 |
| Incorporation of a barrier protection cream in the management of chronic hand dermatitis: focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repair | 13.3 | 0 | 1 |
| Epidermal Permeability Barrier Defects and Barrier Repair Therapy in Atopic Dermatitis | 13.3 | 0 | 1 |
| hyaluronan | 13.3 | 0 | 1 |
| beta-D-GlcpA-(1->3)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpA-(1->3)-D-GlcpNAc | 13.3 | 0 | 1 |
| Cationic liposome–hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens | 13.3 | 0 | 1 |
| Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation | 13.3 | 0 | 1 |
| Perpendicular Strut Injection of Hyaluronic Acid Filler for Deep Wrinkles | 13.3 | 0 | 1 |
| Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution | 13.3 | 0 | 1 |
| Hyaluronic acid: molecular conformations and interactions in two sodium salts | 13.3 | 0 | 1 |
| Hyaluronic acid: Structure of a fully extended 3-fold helical sodium salt and comparison with the less extended 4-fold helical forms | 13.3 | 0 | 1 |
| Mechanisms of chemical-induced innate immunity in allergic contact dermatitis | 13.3 | 0 | 1 |
| Hyaluronic acid: The role of divalent cations in conformation and packing | 13.3 | 0 | 1 |
| Novel concept of iSALT (inducible skin-associated lymphoid tissue) in the elicitation of allergic contact dermatitis | 13.3 | 0 | 1 |
| Skin barrier in rosacea | 13.3 | 0 | 1 |
| Skin rejuvenation using cosmetic products containing growth factors, cytokines, and matrikines: a review of the literature | 13.3 | 0 | 1 |
| Hyaluronic acid fillers with cohesive polydensified matrix for soft-tissue augmentation and rejuvenation: a literature review | 13.3 | 0 | 1 |
| Developing food allergy: a potential immunologic pathway linking skin barrier to gut | 13.3 | 0 | 1 |
| Volumetric techniques: three-dimensional midface modeling | 13.3 | 0 | 1 |
| Hyaluronic Acid: Perspectives in Upper Aero-Digestive Tract. A Systematic Review | 13.3 | 0 | 1 |
| Effectiveness of hyaluronic acid administration in treating adhesive capsulitis of the shoulder: a systematic review of randomized controlled trials | 13.3 | 0 | 1 |
| Targeting transporters: Promoting blood–brain barrier repair in response to oxidative stress injury | 13.3 | 0 | 1 |
| CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration | 13.3 | 0 | 1 |
| Adore Beauty | 13.3 | 0 | 1 |
| Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells | 13.3 | 0 | 1 |
| Neonatal skin care: the scientific basis for practice | 13.3 | 0 | 1 |
| Allergic contact dermatitis from triethanolamine in a sunscreen | 13.3 | 0 | 1 |
| Skin irritation and dryness associated with two hand-hygiene regimens: soap-and-water hand washing versus hand antisepsis with an alcoholic hand gel | 13.3 | 0 | 1 |
| Cosmetics and skin care products. A historical perspective | 13.3 | 0 | 1 |
| Tetrazepam allergy once more detected by patch test | 13.3 | 0 | 1 |
| Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors | 13.3 | 0 | 1 |
| Effect of Centella asiatica Linn on physical and chemical factors induced gastric ulceration and secretion in rats | 13.3 | 0 | 1 |
| Non-steroidal and steroidal anti-inflammatory drugs vary in their modulation of dendritic cell function in the elicitation phase of allergic contact dermatitis | 13.3 | 0 | 1 |
| Skin care management: educational aspects | 13.3 | 0 | 1 |
| Emblica cascading antioxidant: a novel natural skin care ingredient | 13.3 | 0 | 1 |
| Role of vitamins in skin care | 13.3 | 0 | 1 |
| The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes | 13.3 | 0 | 1 |
| Allergic contact dermatitis | 13.3 | 0 | 1 |
| Tetrazepam drug sensitivity -- usefulness of the patch test | 13.3 | 0 | 1 |
| The skin barrier as an innate immune element | 13.3 | 0 | 1 |
| Evidence-Based Skin Care Management in Radiation Therapy: Clinical Update | 13.3 | 0 | 1 |
| Short-term effects of alcohol-based disinfectant and detergent on skin irritation | 13.3 | 0 | 1 |
| Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins | 13.3 | 0 | 1 |
| Filaggrin in the frontline: role in skin barrier function and disease | 13.3 | 0 | 1 |
| Allergic contact dermatitis to cocamidopropyl betaine in shampoo | 13.3 | 0 | 1 |
| Dynamic cytoplasmic anchoring of the transcription factor Bach1 by intracellular hyaluronic acid binding protein IHABP | 13.3 | 0 | 1 |
| Occupational airborne contact dermatitis from sporadic exposure to tetrazepam during machine maintenance | 13.3 | 0 | 1 |
| A novel method to inject hyaluronic acid: the Fern Pattern Technique | 13.3 | 0 | 1 |
| Contact dermatitis allergy to common ivy (Hedera helix L.) | 13.3 | 0 | 1 |
| Allergic contact dermatitis resulting from sensitivity to citrus peel, geraniol, and citral | 13.3 | 0 | 1 |
| Skin care practices for newborns and infants: review of the clinical evidence for best practices | 13.3 | 0 | 1 |
| Safety of blocking vascular adhesion protein-1 in patients with contact dermatitis | 13.3 | 0 | 1 |
| Contact dermatitis due to lanoconazole, cetyl alcohol and diethyl sebacate in lanoconazole cream | 13.3 | 0 | 1 |
| Evidence-based skin care management in radiation therapy | 13.3 | 0 | 1 |
| Histoplasmin skin sensitivity in Nova Scotia | 13.3 | 0 | 1 |
| The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin | 13.3 | 0 | 1 |
| The benefits of implementing a new skin care protocol in nursing homes | 13.3 | 0 | 1 |
| The validity of skin care protocols followed by women with breast cancer receiving external radiation | 13.3 | 0 | 1 |
| Allergy to cocamidopropyl betaine may be due to amidoamine: a patch test and product use test study | 13.3 | 0 | 1 |
| Allergic contact dermatitis following aromatherapy with valiya narayana thailam--an ayurvedic oil presenting as exfoliative dermatitis | 13.3 | 0 | 1 |
| Evidence-Based Skin Care: A Systematic Literature Review and the Development of a Basic Skin Care Algorithm | 13.3 | 0 | 1 |
| Skin Care | 13.3 | 0 | 1 |
| Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers | 13.3 | 0 | 1 |
| In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen | 13.3 | 0 | 1 |
| Safety and efficacy of clocortolone pivalate 0.1 percent cream in the treatment of atopic dermatitis, contact dermatitis, and seborrheic dermatitis | 13.3 | 0 | 1 |
| The effectiveness of jewelweed, Impatiens capensis, the related cultivar I. balsamina and the component, lawsone in preventing post poison ivy exposure contact dermatitis | 13.3 | 0 | 1 |
| Allergic contact dermatitis to ethoxyquin in a farmer handling chicken feeds | 13.3 | 0 | 1 |
| Allergic contact dermatitis to cocamidopropylbetaine in hair shampoo | 13.3 | 0 | 1 |
| The Infant Skin Barrier: Can We Preserve, Protect, and Enhance the Barrier? | 13.3 | 0 | 1 |
| Studies on the role of leukotrienes in murine allergic and irritant contact dermatitis | 13.3 | 0 | 1 |
| Assignment of cDNA Encoding Hyaluronic Acid-Binding Protein 1 to Human Chromosome 17p12–p13 | 13.3 | 0 | 1 |
| Purification, partial characterization of rat kidney hyaluronic acid binding protein and its localization on the cell surface | 13.3 | 0 | 1 |
| Contact dermatitis from Grevillea 'Robyn Gordon' | 13.3 | 0 | 1 |
| Severe contact dermatitis caused by mephenesin | 13.3 | 0 | 1 |
| Innovations in natural ingredients and their use in skin care | 13.3 | 0 | 1 |
| Allergic contact dermatitis caused by mushrooms. A case report and literature review | 13.3 | 0 | 1 |
| Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study | 13.3 | 0 | 1 |
| A survey of skin problems and skin care regimens in the elderly | 13.3 | 0 | 1 |
| A case of contact dermatitis due to impurities of cetyl alcohol | 13.3 | 0 | 1 |
| Articular Cartilage Regeneration With Autologous Peripheral Blood Progenitor Cells and Hyaluronic Acid After Arthroscopic Subchondral Drilling: A Report of 5 Cases With Histology | 13.3 | 0 | 1 |
| Allergic contact dermatitis to ethylenediamine. A continuing problem | 13.3 | 0 | 1 |
| Tetrazepam allergy detected by patch test | 13.3 | 0 | 1 |
| Allergic contact dermatitis releases soluble factors that stimulate melanogenesis through activation of protein kinase C-related signal-transduction pathway | 13.3 | 0 | 1 |
| A murine in vitro model of allergic contact dermatitis to sesquiterpene alpha-methylene-gamma-butyrolactones | 13.3 | 0 | 1 |
| The leukocyte migration test in nickel contact dermatitis | 13.3 | 0 | 1 |
| Lymphocyte transformation induced by nickel sulphate: an in vitro study of subjects with and without a positive nickel patch test | 13.3 | 0 | 1 |
| Recurrent angioneurotic oedema and contact dermatitis due to penicillin | 13.3 | 0 | 1 |
| Allergic contact dermatitis to isopropylaminodiphenylamine (IPPD) | 13.3 | 0 | 1 |
| A New Animal Model for Contact Dermatitis: The Hairless Guinea Pig | 13.3 | 0 | 1 |
| Contact allergies to topical corticosteroids: 10 cases of contact dermatitis | 13.3 | 0 | 1 |
| Brilliant Lake Red R as a cause of pigmented contact dermatitis | 13.3 | 0 | 1 |
| Steroid sulfatase activity in epidermis of acne-prone and non-acne-prone skin of patients with acne vulgaris | 13.3 | 0 | 1 |
| Synthesis of and allergic contact dermatitis to bicyclo-[2,2,1]-heptyl-α-methylene-γ-butyrolactones derived from norbornene and camphene | 13.3 | 0 | 1 |
| Hexachlorophene emulsions and antiseptic skin care of newborn infants | 13.3 | 0 | 1 |
| Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid | 13.3 | 0 | 1 |
| Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis | 13.3 | 0 | 1 |
| Allergic contact dermatitis to underwear elastic. Chemically transformed by laundry bleach | 13.3 | 0 | 1 |
| Allergic contact dermatitis from dental composite resins due to aromatic epoxy acrylates and aliphatic acrylates | 13.3 | 0 | 1 |
| Allergic contact dermatitis from 1,2-dichloropropane | 13.3 | 0 | 1 |
| Allergic contact dermatitis from topical corticosteroids | 13.3 | 0 | 1 |
| Allergic Contact Dermatitis to Low Molecular Weight Allergens in the Chicken | 13.3 | 0 | 1 |
| Nickel-induced proliferation of both memory and naive T cells in patch test-negative individuals | 13.3 | 0 | 1 |
| Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients | 13.3 | 0 | 1 |
| A comparative study of the expression of cytotoxic proteins in allergic contact dermatitis and psoriasis: spongiotic skin lesions in allergic contact dermatitis are highly infiltrated by T cells expressing perforin and granzyme B | 13.3 | 0 | 1 |
| Contact dermatitis in students practicing sports: incidence of rubber sensitisation | 13.3 | 0 | 1 |
| Quantification of allergic and irritant patch test reactions using ImageJ | 13.3 | 0 | 1 |
| Allergic contact dermatitis from 3-iodo-2-propynyl-butylcarbamate in a cosmetic cream | 13.3 | 0 | 1 |
| Serotonin in human allergic contact dermatitis. An immunohistochemical and high-performance liquid chromatographic study | 13.3 | 0 | 1 |
| The prevalence and possible causes of contact dermatitis in farmworkers | 13.3 | 0 | 1 |
| Halometasone monohydrate (0.05%) in occupational contact dermatitis | 13.3 | 0 | 1 |
| Few Associations Found between Mold and Other Allergen Concentrations in the Home versus Skin Sensitivity from Children with Asthma after Hurricane Katrina in the Head-Off Environmental Asthma in Louisiana Study | 13.3 | 0 | 1 |
| Skin barrier homeostasis in atopic dermatitis: feedback regulation of kallikrein activity | 13.3 | 0 | 1 |
| Open Beauty Facts | 13.3 | 0 | 1 |
| Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans | 13.3 | 0 | 1 |
| Harlequin ichthyosis model mouse reveals alveolar collapse and severe fetal skin barrier defects | 13.3 | 0 | 1 |
| Temporally controlled targeted somatic mutagenesis in embryonic surface ectoderm and fetal epidermal keratinocytes unveils two distinct developmental functions of BRG1 in limb morphogenesis and skin barrier formation | 13.3 | 0 | 1 |
| Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice | 13.3 | 0 | 1 |
| CD44 Binding to Hyaluronic Acid Is Redox Regulated by a Labile Disulfide Bond in the Hyaluronic Acid Binding Site | 13.3 | 0 | 1 |
| Sustained Effect of Hyaluronic Acid in Subcutaneous Administration to the Cochlear Spiral Ganglion | 13.3 | 0 | 1 |
| Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model | 13.3 | 0 | 1 |
| Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome | 13.3 | 0 | 1 |
| Superresolution and Fluorescence Dynamics Evidence Reveal That Intact Liposomes Do Not Cross the Human Skin Barrier | 13.3 | 0 | 1 |
| Hyaluronan binding protein 2 | 13.3 | 0 | 1 |
| Hyaluronan synthase 2 | 13.3 | 0 | 1 |
| Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44 | 13.3 | 0 | 1 |
| Assessment of skin irritation and molecular responses in rat skin exposed to nonane, dodecane and tetradecane | 13.3 | 0 | 1 |
| Effect of methyl substitution of benzene on the percutaneous absorption and skin irritation in hairless rats | 13.3 | 0 | 1 |
| The effect of hyaluronic acid size and concentration on branching morphogenesis and tubule differentiation in developing kidney culture systems: potential applications to engineering of renal tissues | 13.3 | 0 | 1 |
| Changes in brain biogenic amines and haem biosynthesis and their response to combined administration of succimers and Centella asiatica in lead poisoned rats | 13.3 | 0 | 1 |
| Lipopenia and skin barrier abnormalities in DGAT2-deficient mice | 13.3 | 0 | 1 |
| GPHR-dependent functions of the Golgi apparatus are essential for the formation of lamellar granules and the skin barrier | 13.3 | 0 | 1 |
| Excessive reactive oxygen species induces apoptosis in fibroblasts: role of mitochondrially accumulated hyaluronic acid binding protein 1 (HABP1/p32/gC1qR) | 13.3 | 0 | 1 |
| Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein | 13.3 | 0 | 1 |
| Increased retinoic acid levels through ablation of Cyp26b1 determine the processes of embryonic skin barrier formation and peridermal development | 13.3 | 0 | 1 |
| Comparative study of normal and sensitive skin aerobic bacterial populations | 13.3 | 0 | 1 |
| Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation | 13.3 | 0 | 1 |
| Diclofenac-Induced Allergic Contact Dermatitis: A Series of Four Patients | 13.3 | 0 | 1 |
| In vitro and In vivo Antioxidant, Anti-hyperlipidemic Properties and Chemical Characterization of Centella asiatica (L.) Extract | 13.3 | 0 | 1 |
| Use of silicon for skin and hair care: an approach of chemical forms available and efficacy | 13.3 | 0 | 1 |
| The enlightenment from Malaysian consumers' perspective toward cosmetic products | 13.3 | 0 | 1 |
| Induction of Cancer Cell Death by Hyaluronic Acid-Mediated Uptake of Cytochrome C | 13.3 | 0 | 1 |
| ile de beaute | 13.3 | 0 | 1 |
| Hyaluronic acid-modified multifunctional Q-graphene for targeted killing of drug-resistant lung cancer cells | 13.3 | 0 | 1 |
| A Survey of Skin Problems and Skin Care Regimens in the Elderly | 13.3 | 0 | 1 |
| Bolden | 13.3 | 0 | 1 |
| Seeking Clearer Recommendations for Hand Hygiene in Communities Facing Ebola: A Randomized Trial Investigating the Impact of Six Handwashing Methods on Skin Irritation and Dermatitis | 13.3 | 0 | 1 |
| CONTACT DERMATITIS OF THE FACE DUE TO MATCHES | 13.3 | 0 | 1 |
| The Validity and Practicality of Sun-Reactive Skin Types I Through VI | 13.3 | 0 | 1 |
| Hyaluronan binding protein 4 | 13.3 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 13.3 | 0 | 1 |
| Hyaluronan-mediated motility receptor | 13.3 | 0 | 1 |
| Contact hypersensitivity and allergic contact dermatitis among school children and teenagers with eczema | 13.3 | 0 | 1 |
| LOC563048 | 13.3 | 0 | 1 |
| Allergic contact dermatitis resulting from sensitivity to citrus peel, geraniol, and citral | 13.3 | 0 | 1 |
| Complications of Injectable Fillers, Part 2: Vascular Complications | 13.3 | 0 | 1 |
| Reactive skin decontamination lotion (RSDL) for the decontamination of chemical warfare agent (CWA) dermal exposure | 13.3 | 0 | 1 |
| Introduction of community-based skin-to-skin care in rural Uttar Pradesh, India | 13.3 | 0 | 1 |
| Use of Intra-Articular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice | 13.3 | 0 | 1 |
| Hair-care practices in African American women: potential for allergic contact dermatitis | 13.3 | 0 | 1 |
| Universal Beauty Products (United States) | 13.3 | 0 | 1 |
| Michigan Center for Skin Care Research | 13.3 | 0 | 1 |
| New York Laser and Skin Care | 13.3 | 0 | 1 |
| Skin Care and Laser Physicians of Beverly Hills | 13.3 | 0 | 1 |
| Hyaluronan Research Institute | 13.3 | 0 | 1 |
| Gold Skin Care Center | 13.3 | 0 | 1 |
| Associated Skin Care Specialists | 13.3 | 0 | 1 |
| Perineal skin care for the incontinent patient | 13.3 | 0 | 1 |
| Tender mercies: providing skin care for an incontinent patient | 13.3 | 0 | 1 |
| Protecting perineal skin integrity. Incontinent patients present unique challenges to successful skin care management. | 13.3 | 0 | 1 |
| E45 cream | 13.3 | 0 | 1 |
| Study of the effect of mixing approach on cross-linking efficiency of hyaluronic acid-based hydrogel cross-linked with 1,4-butanediol diglycidyl ether | 13.3 | 0 | 1 |
| Development and characterization of microemulsions containing hyaluronic acid | 13.3 | 0 | 1 |
| Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer | 13.3 | 0 | 1 |
| Bioactivity of immobilized hyaluronic acid derivatives regarding protein adsorption and cell adhesion. | 13.3 | 0 | 1 |
| Incorporating skin care into a facial plastic surgery practice | 13.3 | 0 | 1 |
| Optical clearing of skin enhanced with hyaluronic acid for increased contrast of optoacoustic imaging. | 13.3 | 0 | 1 |
| Trehalose and hyaluronic acid coordinately stabilized freeze-dried pancreatic kininogenase. | 13.3 | 0 | 1 |
| Nanotubes-Embedded Indocyanine Green-Hyaluronic Acid Nanoparticles for Photoacoustic-Imaging-Guided Phototherapy | 13.3 | 0 | 1 |
| Evaluation of Hyaluronic Acid Dilutions at Different Concentrations Using a Quartz Crystal Resonator (QCR) for the Potential Diagnosis of Arthritic Diseases | 13.3 | 0 | 1 |
| Complex coacervates of hyaluronic acid and lysozyme: effect on protein structure and physical stability | 13.3 | 0 | 1 |
| Clinically tested toothpaste and other fairy tales - a critical approach to reading pharmaceutical advertisements and professional papers. | 13.3 | 0 | 1 |
| Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C. | 13.3 | 0 | 1 |
| Skin Barrier Defects in Atopic Dermatitis | 13.3 | 0 | 1 |
| Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors | 13.3 | 0 | 1 |
| Controllably local gene delivery mediated by polyelectrolyte multilayer films assembled from gene-loaded nanopolymersomes and hyaluronic acid | 13.3 | 0 | 1 |
| Do you know where your fillers go? An ultrastructural investigation of the lips | 13.3 | 0 | 1 |
| Factors correlating with acoustic radiation force impulse elastography in chronic hepatitis C | 13.3 | 0 | 1 |
| In vitro cultivation of canine multipotent mesenchymal stromal cells on collagen membranes treated with hyaluronic acid for cell therapy and tissue regeneration. | 13.3 | 0 | 1 |
| Quality of the voice after injection of hyaluronic acid into the vocal fold | 13.3 | 0 | 1 |
| Preliminary histopathological study of intra-articular injection of a novel highly cross-linked hyaluronic acid in a rabbit model of knee osteoarthritis | 13.3 | 0 | 1 |
| Recent Trends in the Surgical Management of Primary Vesicoureteral Reflux in the Era of Dextranomer/Hyaluronic Acid | 13.3 | 0 | 1 |
| First Report of Septoria centellae Associated with Leaf Spot of Centella asiatica in Korea | 13.3 | 0 | 1 |
| The design of in vitro liver sinusoid mimics using chitosan-hyaluronic acid polyelectrolyte multilayers | 13.3 | 0 | 1 |
| Pharmacological review on Centella asiatica: A potential herbal cure-all | 13.3 | 0 | 1 |
| Promotion of osteoblast proliferation on complex coacervation-based hyaluronic acid - recombinant mussel adhesive protein coatings on titanium | 13.3 | 0 | 1 |
| Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation | 13.3 | 0 | 1 |
| Allergic contact dermatitis to colophony in a violoncellist | 13.3 | 0 | 1 |
| The alarmin Mrp8/14 as regulator of the adaptive immune response during allergic contact dermatitis | 13.3 | 0 | 1 |
| Allergic contact dermatitis in a violinist. The role of abietic acid--a sensitizer in rosin (colophony)--as the causative agent. | 13.3 | 0 | 1 |
| Allergic contact dermatitis on a violinist's neck from para‐phenylenediamine in a chin rest stain | 13.3 | 0 | 1 |
| Allergic contact dermatitis from colophony and Compositae in a violinist | 13.3 | 0 | 1 |
| Allergic contact dermatitis from colophonium, turpentine and ebony in a violinist presenting as fiddler's neck | 13.3 | 0 | 1 |
| Allergic contact dermatitis to purpleheart and padauk wood (Pterocarpus dalbergiodes). | 13.3 | 0 | 1 |
| Occlusive irritant dermatitis: when is "allergic" contact dermatitis not allergic? | 13.3 | 0 | 1 |
| Allergic contact dermatitis of the lips in a recorder player caused by African blackwood | 13.3 | 0 | 1 |
| Surface treatment of flexor tendon autografts with carbodiimide-derivatized hyaluronic Acid. An in vivo canine model | 13.3 | 0 | 1 |
| Fiddler's neck: Chin rest-associated irritant contact dermatitis and allergic contact dermatitis in a violin player | 13.3 | 0 | 1 |
| Applicability of in vitro tests for skin irritation and corrosion to regulatory classification schemes: Substantiating test strategies with data from routine studies | 13.3 | 0 | 1 |
| Effect of vehicles and elicitation concentration in contact dermatitis testing II. Statistical analysis of data | 13.3 | 0 | 1 |
| Occupational contact dermatitis in hairdressers/cosmetologists: retrospective analysis of north american contact dermatitis group data, 1994 to 2010. | 13.3 | 0 | 1 |
| Significance-prevalence index number: a reinterpretation and enhancement of data from the North American contact dermatitis group | 13.3 | 0 | 1 |
| Hyaluronic acid synthase | 13.3 | 0 | 1 |
| CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility | 13.3 | 0 | 1 |
| Erratum to “Applicability of in vitro tests for skin irritation and corrosion to regulatory classification schemes: Substantiating test strategies with data from routine studies” [Regul. Toxicol. Pharmacol. (2012) 402–414] | 13.3 | 0 | 1 |
| Molecular weight determination of hyaluronic acid by gel filtration chromatography coupled to matrix-assisted laser desorption ionization mass spectrometry | 13.3 | 0 | 1 |
| Matrix metalloproteinase, hyaluronidase and elastase inhibitory potential of standardized extract ofCentella asiatica | 13.3 | 0 | 1 |
| Separation of chondroitin sulfate and hyaluronic acid fragments by centrifugal precipitation chromatography | 13.3 | 0 | 1 |
| Solution structure of hyaluronic acid oligomers by experimental and theoretical NMR, and molecular dynamics simulation | 13.3 | 0 | 1 |
| Allergic contact dermatitis due to benzalkonium chloride in plaster of Paris | 13.3 | 0 | 1 |
| Thermoresponsive Artificial Extracellular Matrix for Tissue Engineering: Hyaluronic Acid Bioconjugated with Poly(N-isopropylacrylamide) Grafts | 13.3 | 0 | 1 |
| In vivo nickel allergic contact dermatitis: human model for topical therapeutics | 13.3 | 0 | 1 |
| Evaluation of an experimental patch test model for the detection of irritant skin reactions to moisturisers. | 13.3 | 0 | 1 |
| Using OASIS data to improve skin care | 13.3 | 0 | 1 |
| Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation | 13.3 | 0 | 1 |
| Hyaluronic acid and alginate covalent nanogels by template cross-linking in polyion complex micelle nanoreactors | 13.3 | 0 | 1 |
| Effect of hyaluronic acid on corneal haze in a photorefractive keratectomy experimental model. | 13.3 | 0 | 1 |
| CD44-targeted docetaxel conjugate for cancer cells and cancer stem-like cells: a novel hyaluronic acid-based drug delivery system | 13.3 | 0 | 1 |
| Hyaluronic acid in the rabbit cornea after excimer laser superficial keratectomy | 13.3 | 0 | 1 |
| Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging | 13.3 | 0 | 1 |
| Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella asiatica: A Prospective, Placebo-Controlled Randomized Study | 13.3 | 0 | 1 |
| Flight Microangiopathy in Medium-to Long-Distance Flights: Prevention of Edema and Microcirculation Alterations with Total Triterpenic Fraction of Centella asiatica | 13.3 | 0 | 1 |
| Microcirculatory Effects of Total Triterpenic Fraction of Centella asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-co2, and Leg Volumetry | 13.3 | 0 | 1 |
| Evaluation of Treatment of Diabetic Microangiopathy with Total Triterpenic Fraction of Centella asiatica: A Clinical Prospective Randomized Trial with a Microcirculatory Model | 13.3 | 0 | 1 |
| Total Triterpenic Fraction of Centella asiatica in the Treatment of Venous Hypertension: A Clinical, Prospective, Randomized Trial Using a Combined Microcirculatory Model | 13.3 | 0 | 1 |
| The effect of ultrapure hyaluronic acid with different molecular weights on the healing of porcine full thickness skin wound | 13.3 | 0 | 1 |
| Investigation of the Viability, Adhesion, and Migration of Human Fibroblasts in a Hyaluronic Acid/Gelatin Microgel-Reinforced Composite Hydrogel for Vocal Fold Tissue Regeneration. | 13.3 | 0 | 1 |
| Nanostructured polymeric coatings based on chitosan and dopamine-modified hyaluronic acid for biomedical applications. | 13.3 | 0 | 1 |
| The role of hyaluronic acid capsular material of Streptococcus equi subsp. zooepidemicus in mediating adherence to HeLa cells and in resisting phagocytosis | 13.3 | 0 | 1 |
| Characterization of porous collagen/hyaluronic acid scaffold modified by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide cross-linking | 13.3 | 0 | 1 |
| Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review | 13.3 | 0 | 1 |
| Platelet-derived Factor Concentrates with Hyaluronic Acid Scaffolds for Treatment of Deep Burn Wounds | 13.3 | 0 | 1 |
| Near Infrared Fluorescent Nanoparticles Derived from Hyaluronic Acid Improve Tumor Contrast for Image-Guided Surgery | 13.3 | 0 | 1 |
| Nasal Reshaping with Hyaluronic Acid: An Alternative or Complement to Surgery | 13.3 | 0 | 1 |
| Current trends in patch testing - new data from the German Contact Dermatitis Research Group (DKG) and the Information Network of Departments of Dermatology (IVDK). | 13.3 | 0 | 1 |
| Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations | 13.3 | 0 | 1 |
| Anchoring molecular mechanisms to the adverse outcome pathway for skin sensitization: Analysis of existing data | 13.3 | 0 | 1 |
| Predicting visual assessment of allergic patch test reactions by non-invasive measurements | 13.3 | 0 | 1 |
| Skin sensitivity and intolerance in Shanghai: cumulative influence of different meteorological parameters | 13.3 | 0 | 1 |
| A novel crosslinked hyaluronic acid nanogel for drug delivery | 13.3 | 0 | 1 |
| Thermoresponsive hyaluronic acid nanogels as hydrophobic drug carrier to macrophages. | 13.3 | 0 | 1 |
| Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. | 13.3 | 0 | 1 |
| Using Medicare data to understand low-value health care: the case of intra-articular hyaluronic acid injections | 13.3 | 0 | 1 |
| Quantification of allergic and irritant patch test reactions using laser-Doppler flowmetry and erythema index | 13.3 | 0 | 1 |
| Contact dermatitis of the hands in housewives: preliminary data of a multicenter study | 13.3 | 0 | 1 |
| Body piercing and metal allergic contact sensitivity: North American contact dermatitis group data from 2007 to 2010. | 13.3 | 0 | 1 |
| Contact allergy trends in Sweden - a retrospective comparison of patch test data from 1992, 2000, and 2009. | 13.3 | 0 | 1 |
| Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings | 13.3 | 0 | 1 |
| Cellulose derivative-hyaluronic acid-based microporous hydrogels cross-linked through divinyl sulfone (DVS) to modulate equilibrium sorption capacity and network stability | 13.3 | 0 | 1 |
| Consumption of cosmetic products by the French population. First part: Frequency data | 13.3 | 0 | 1 |
| Novel administration technique for large-particle stabilized hyaluronic acid-based gel of nonanimal origin in facial tissue augmentation | 13.3 | 0 | 1 |
| Hapten selection for patch tests in the diagnosis of allergic contact dermatitis: epidemiologic data | 13.3 | 0 | 1 |
| A comparison of molecular mass determination of hyaluronic acid using SEC/MALLS and sedimentation equilibrium | 13.3 | 0 | 1 |
| 1H- and 13C-NMR studies of solutions of hyaluronic acid esters and salts in methyl sulfoxide: comparison of hydrogen-bond patterns and conformational behaviour | 13.3 | 0 | 1 |
| Probing the role of the ceramide acyl chain length and sphingosine unsaturation in model skin barrier lipid mixtures by (2)H solid-state NMR spectroscopy | 13.3 | 0 | 1 |
| Hyaluronic Acid Filler in HIV-Associated Facial Lipoatrophy: Evaluation of Tissue Distribution and Morphology with MRI. | 13.3 | 0 | 1 |
| Assessment of nonpenetrating deep sclerectomy with reticulated hyaluronic acid implant SKGEL and/or preoperative application of 5-luorouracil: results of 2 and a half years | 13.3 | 0 | 1 |
| Preparation of cross-linked hyaluronic acid film using 2-chloro-1-methylpyridinium iodide or water-soluble 1-ethyl-(3,3-dimethylaminopropyl)carbodiimide | 13.3 | 0 | 1 |
| Prevalence and relevance of contact dermatitis allergens: a meta-analysis of 15 years of published T.R.U.E. test data | 13.3 | 0 | 1 |
| Detection of skin irritation potential of cosmetics by non-invasive measurements | 13.3 | 0 | 1 |
| Morphologic and immunohistochemical features of experimentally induced allergic contact dermatitis in Göttingen minipigs | 13.3 | 0 | 1 |
| Exposure data for cosmetic products: lipstick, body lotion, and face cream | 13.3 | 0 | 1 |
| Serum hyaluronic acid levels are elevated in arthritis patients, but normal and not associated with clinical data in patients with fibromyalgia syndrome. | 13.3 | 0 | 1 |
| Skin irritation: prevalence, variability, and regulatory classification of existing in vivo data from industrial chemicals | 13.3 | 0 | 1 |
| Epidemiological data on airborne contact dermatitis – results of the IVDK | 13.3 | 0 | 1 |
| Determination of modification degree in BDDE-modified hyaluronic acid hydrogel by SEC/MS | 13.3 | 0 | 1 |
| Contact allergy to methyldibromo glutaronitrile--data from a 'front line' network | 13.3 | 0 | 1 |
| Thermosensitive hydrogels composed of hyaluronic acid and gelatin as carriers for the intravesical administration of cisplatin | 13.3 | 0 | 1 |
| Molecular cloning of rabbit hyaluronic acid synthases and their expression patterns in synovial membrane and articular cartilage | 13.3 | 0 | 1 |
| A new method to model change in cutaneous blood flow due to mechanical skin irritation part I: comparison between experimental and numerical data | 13.3 | 0 | 1 |
| Evaluation of patch test data using a personal computer system | 13.3 | 0 | 1 |
| Computerized patch test data collection and analysis | 13.3 | 0 | 1 |
| Patch test preparations of mercury ammonium chloride under the microscope | 13.3 | 0 | 1 |
| Do cool water or physiologic saline compresses enhance resolution of experimentally-induced irritant contact dermatitis? | 13.3 | 0 | 1 |
| Co-occurring words and retrieval efficiency: finding information about alternatives to animal testing in relation to skin irritation testing | 13.3 | 0 | 1 |
| Neck skin rejuvenation: Histological and clinical changes after combined therapy with a fractional non-ablative laser and stabilized hyaluronic acid-based gel of non-animal origin | 13.3 | 0 | 1 |
| Kinetic analysis on the skin disposition of cytotoxicity as an index of skin irritation produced by cetylpyridinium chloride: comparison of in vitro data using a three-dimensional cultured human skin model with in vivo results in hairless mice | 13.3 | 0 | 1 |
| Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis | 13.3 | 0 | 1 |
| Correlation between laser Doppler perfusion imaging and visual scoring of patch test sites in subjects with experimentally induced allergic and irritant contact reactions | 13.3 | 0 | 1 |
| Self-reported skin sensitivity in a general adult population in France: data of the SU.VI.MAX cohort | 13.3 | 0 | 1 |
| Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy | 13.3 | 0 | 1 |
| ACP gel: a new hyaluronic acid-based injectable for facial rejuvenation. Preclinical data in a rabbit model | 13.3 | 0 | 1 |
| Guidelines for visualization of cutaneous blood flow by laser Doppler perfusion imaging. A report from the Standardization Group of the European Society of Contact Dermatitis based upon the HIRELADO European community project | 13.3 | 0 | 1 |
| Skin irritation typing and grading based on laser Doppler perfusion imaging | 13.3 | 0 | 1 |
| Quantifying Depth of Injection of Hyaluronic Acid in the Dermis: Data from Clinical, Laboratory, and Ultrasound Settings | 13.3 | 0 | 1 |
| Single doses of local betamethasone do not suppress allergic patch test reactions to nickel sulfate | 13.3 | 0 | 1 |
| Instrumental evaluation of retinoid-induced skin irritation | 13.3 | 0 | 1 |
| Allergic contact dermatitis due to beta-blockers in eye drops: a retrospective analysis of multicentre surveillance data 1993-2004. | 13.3 | 0 | 1 |
| Differences of skin irritation between Japanese and European women | 13.3 | 0 | 1 |
| A laser-clinic nurse with allergic contact dermatitis from tetracaine. | 13.3 | 0 | 1 |
| The atopy patch test -- reproducibility and comparison of different evaluation methods | 13.3 | 0 | 1 |
| Patch test results in patients with scalp dermatitis: analysis of data of the Information Network of Departments of Dermatology | 13.3 | 0 | 1 |
| Allergic contact dermatitis from methyldibromo glutaronitrile in a sanitary pad and review of Australian clinic data | 13.3 | 0 | 1 |
| Time trends in Swedish patch test data from 1992 to 2000. A multi-centre study based on age- and sex-adjusted results of the Swedish standard series | 13.3 | 0 | 1 |
| Skin care products and subtle data manipulation | 13.3 | 0 | 1 |
| Common contact allergens associated with eyelid dermatitis: data from the North American Contact Dermatitis Group 2003-2004 study period. | 13.3 | 0 | 1 |
| The effects of polar excipients transcutol and dexpanthenol on molecular mobility, permeability, and electrical impedance of the skin barrier | 13.3 | 0 | 1 |
| Contact dermatitis of the hands: cross-sectional analyses of North American Contact Dermatitis Group Data, 1994-2004. | 13.3 | 0 | 1 |
| Hyaluronic acid derivatives prepared in aqueous media by triazine-activated amidation. | 13.3 | 0 | 1 |
| Fabrication of a bioadhesive transdermal device from chitosan and hyaluronic acid for the controlled release of lidocaine | 13.3 | 0 | 1 |
| Pediatric Contact Dermatitis Registry Inaugural Case Data. | 13.3 | 0 | 1 |
| Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT/MR dual-mode imaging of hepatocellular carcinoma | 13.3 | 0 | 1 |
| Are material safety data sheets (MSDS) useful in the diagnosis and management of occupational contact dermatitis? | 13.3 | 0 | 1 |
| Shoe allergens: retrospective analysis of cross-sectional data from the north american contact dermatitis group, 2001-2004. | 13.3 | 0 | 1 |
| Control of the molecular degradation of hyaluronic acid hydrogels for tissue augmentation. | 13.3 | 0 | 1 |
| Delayed Adverse Subcutaneous Reaction to a New Family of Hyaluronic Acid Dermal Fillers With Clinical, Ultrasound, and Histologic Correlation | 13.3 | 0 | 1 |
| Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study | 13.3 | 0 | 1 |
| Nickel allergy--prevalence in a population of Swedish youths from patch test and questionnaire data | 13.3 | 0 | 1 |
| Characterizing the electrospray-ionization mass spectral fragmentation pattern of enzymatically derived hyaluronic acid oligomers | 13.3 | 0 | 1 |
| A systematic review of randomised controlled trials evaluating the effect of mother/baby skin-to-skin care on successful breast feeding | 13.3 | 0 | 1 |
| Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skin cancer. | 13.3 | 0 | 1 |
| Contact allergy trends in Singapore - a retrospective study of patch test data from 2009 to 2013. | 13.3 | 0 | 1 |
| Improving skin care through data: a pitch for patient safety incident reporting. | 13.3 | 0 | 1 |
| Effects of cross-linking molecular weights in a hyaluronic acid-poly(ethylene oxide) hydrogel network on its properties | 13.3 | 0 | 1 |
| Factors Associated with the Use of Hyaluronic Acid and Corticosteroid Injections among Patients with Radiographically Confirmed Knee Osteoarthritis: A Retrospective Data Analysis. | 13.3 | 0 | 1 |
| Anogenital dermatitis in patients referred for patch testing: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004. | 13.3 | 0 | 1 |
| The value of patch testing patients with a scattered generalized distribution of dermatitis: retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004. | 13.3 | 0 | 1 |
| Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis | 13.3 | 0 | 1 |
| Positive patch-test reactions to mixed dialkyl thioureas: cross-sectional data from the North American Contact Dermatitis Group, 1994 to 2004. | 13.3 | 0 | 1 |
| Patch-testing North American lip dermatitis patients: data from the North American Contact Dermatitis Group, 2001 to 2004. | 13.3 | 0 | 1 |
| Effect of Am-80, a retinoid derivative, on 2, 4-dinitrofluorobenzene-induced contact dermatitis in mice | 13.3 | 0 | 1 |
| Sterile interface keratitis after laser in situ keratomileusis: three episodes in one patient with concomitant contact dermatitis of the eyelids. | 13.3 | 0 | 1 |